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ABSTRACT 
 
Research misconduct has been generally considered a limited issue, occurring in a small 
percentage of research studies.  Studies of the number of article retractions use retraction 
percentages to perpetuate the idea that research misconduct is not a common event, and use 
information in the retraction notice to quantify types of research misconduct and types or research 
error.  However, retractions appear to be the wrong variable with which to assess misconduct rates 
and characteristics. Using final misconduct findings in hard science research from the Office of 
Research Integrity (ORI) for investigations closed from 1993 through 2013, the number of 
publications and subsequent retractions or corrections per final ORI finding was analyzed.  Out of 
167 subjects who received ORI sanctions, 84 (50.3%) had no publications associated with their 
misconduct.   Of the remaining 83 subjects, only 72 had at least one retraction associated with their 
misconduct, i.e., only 43.1% of the all study subjects sanctioned for misconduct had at least one 
retraction from misconduct.  Of the 231 retractions and corrections arising from the sanctioned 
misconduct, only 94 notices (40.7%) gave research misconduct as a cause for the retraction or 
correction.  Thus, the study demonstrates that research misconduct occurs at a greater rate than 
retractions for misconduct are published, and retraction and correction notices cannot be relied 
upon to convey the presence of fraudulent data within the publication.    
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CHAPTER ONE: 
INTRODUCTION 
 
1.1 Prevalence of Research Misconduct 
 In the past, scientists considered the incidence of research misconduct as a rare event 
(Fanelli, 2009; Baerlocher et al., 2010).  A consensus of 40 United Kingdom researchers, in 
forming a priority list of research misconduct behaviors, decided that “(a)lthough there has been 
considerable attention in the scientific literature on the problems of data fabrication and data 
falsification these were absent from our list of the most important forms of misconduct because 
there was majority agreement that these problems were very unlikely to occur.” (Al-Marzouki, 
Roberts, et al., 2005). The prevailing view was that the rarity of research misconduct had little 
negative  effect on the science literature at large.  (Al-Marzouki et al, 2005; Fanelli, 2009; 
Baerlocher et al, 2010).  Extensive media coverage for high-profile misconduct investigations 
encompassing multiple retractions and large sums of grant monies are fast and fleeting, and may 
actually increase the perception of research misconduct as serious but sporadic occurrence. (Zhang 
and Grienseison, 2013).  
 The conflicting attitudes within the research community concerning the nature and degree 
of misconduct complicated studies of research misconduct.  A (very) informal seminar survey of 
doctoral and postdoctoral students found barely half of them considered data farming (i.e, selecting 
or deleting data to ensure a desired result) an offense worthy of censure (Cole, 2014).  On the other 
side, a survey of scientists and institutional researchers by Korenman et al, (1998) indicated that 
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they considered behaviors as unethical if the behaviors were characterized as misconduct.  
Baerlocher et al. (2010) surveyed 127 research authors who published in at least one of four highly-
respected research journals.  Only five authors (4%) stated that they had discovered fraudulent 
data in a project. Oddly, 15 authors (6.7%) stated knowing the manuscript containing fraudulent 
data from the project had been published.  Baerlocher et al. suggested that a misunderstanding over 
the phrasing may have been responsible for the inconsistency, or that some of the authors “did not 
initially wish to admit” to knowing of fraudulent data.  Nonetheless, discrepancies like these shows 
the difficulty in establishing the true extent of misconduct found within research projects.    
 More recent discussions with research investigators and active researchers suggest that the 
incidences of misconduct are far greater than previously thought.  David Wright, Director of the 
Office of Research Integrity (ORI) from 2012-2014, ventured in an interview with EMBO editor 
Holger Breithaupt that scientific misconduct is underreported and is closer to 3% of all funded 
research (Wright and Breithaupt, 2012).  Titus et al. (2008) suggested that the incidence rate of 
misconduct may approach 3 in 100 researchers, based on an ORI-initiated Gallop study of NIH-
funded researchers (Wells, 2008). The study forms provided the poll participants the federal 
definition of misconduct: “fabrication, falsification, or plagiarism in proposing, performing, or 
reviewing research, or in reporting research results” (OSTP, 2000).   
 Titus et al. further pointed out a curious finding; although the federal definition of 
misconduct was provided in the survey, the NIH-funded researchers characterized some behaviors 
they had witnessed as misconduct, despite a lack of coherence with the federal definition. They 
proposed that this anomaly suggested the federal definition is too narrow; what is unknown is if a 
narrow definition of misconduct implies an illicit encouragement of a wider range of questionable 
research practices.  Gino and Bazerman (2009)  examined the propensity of study subjects to find 
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unethical behavior acceptable if the behavior develops over time rather than appearing suddenly.  
They referred to the phenomenon as “erosion” of ethical standards. They also suggested that in 
such situations, people cease to even notice the unethical behaviors.  Should this effect be true, 
determination of rate of research misconduct by conducting any survey or study of observers 
reporting misconduct events would likely be an underestimation of research misconduct incidence.    
 
1.2  Retraction Studies Enter the Picture 
 In the 1990’s, retractions studies grew in response to the increasing awareness of research 
misconduct. The retraction studies tended to downplay ; the small percentage of retractions 
compared to the increasing number of articles portrayed the misconduct problem as negligible 
even while some statistical analyses suggested that retractions should be occurring in greater 
quantities (Cokel et al., 2007)    
 However, these initial studies of retractions were very limited by a lack of information 
contained in the retraction and correction notices (Pfeifer and Snodgrass, 1990); many journals 
were still only in print form.  Nonetheless, tracking retractions flourished in studies of research 
and publishing misconduct, and soon became synonymous with studies of scientific misconduct. 
Soon the incidence of retractions became perceived as the quantification of misconduct. 
 Retraction studies generally followed a standard methodology.  A database was chosen, 
(generally Pubmed or MEDLINE), keywords such as “retracted publication” and/or “retraction” 
were used for the database search, and the retractions found were then categorized for fraud, error, 
plagiarism, or non-reproducibility, based on the information provided in the notice. Some studies 
modify the categories for more specificity.  Journal impact factor, country of author(s) origin, 
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number of authors, and author placement in the author list were generally included in the dataset; 
different studies modified or expanded the dataset categories. 
 
1.3 Attempts to Characterize Misconduct 
 Various traits were studied of the authors of retracted articles, and were generally limited 
to the information provided in the article and any retraction or correction notice, or with notices 
occurring from some assigned cause.  Some studies associated the sanction author’s placement in 
the author list; Wooley et al (2011) and Stretton et al. (2012) proposed an association between first 
authors, low-income countries, and retractions for misconduct.  A common theme among studies 
proposed that journals with higher impact factors (e.g., greater than 10) are targeted by  fraudulent 
researchers (Grieneisen and Zhang, 2012; Fang et al, 2013).   Fraudulent articles authored by junior 
researchers were retracted sooner than those of senior researchers ((Trikalinos et al., 2008.), but 
no difference was apparent between research fields.  Retraction studies adopt and discard 
associations depending on how much information they gather beyond that of the retraction notice.  
After originally assigning the majority cause of retractions to error in earlier works, Fang et al 
(2012) attributed misconduct as the majority cause when additional research allowed the 
reclassification of a number of retractions.   
 Researchers of retractions are also as likely to remain bound to prior associations, despite 
evidence to the contrary.  Steen and Hammer (2014) noted that anesthesiology had a 
disproportionate number of retractions in their dataset and “strongly” disagreed with the  
Trikalinos et al. (2008) finding of no associations with misconduct retractions and field of study.    
Steen and Hammer posited that “anesthesiology is the field most prone to retraction”, but followed 
up by stating “Still, without Reuben, anesthesiology would not be more corrupted by misconduct 
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than any other medical field.” What merits notice is that “Reuben” referred to Scott Reuben, an 
anesthesiologist who was responsible for 63.6% of the retractions, a calculation made in that same 
study by Steen and Hammer.   
 
1.4  Problems with Retraction Studies 
 While studies on retractions may provide valuable information on publishing tendencies, 
they are less likely to allow for the characterization of misconduct.  For example, one study used 
PUBMED as the database to locate retractions, using the filter “items with abstracts, retracted 
publication, English”, then stated that the study showed “unequivocally that scientists in the USA 
are responsible for more retracted papers than any other country” (Steen, 2010).  While Pubmed 
is a remarkable source of literature with an expansive database, limiting the language to English 
would be likely to skew the findings away from non-English speaking countries who fail to 
produce adequate translations.  Assuming then, one wished to draw conclusions only about 
countries with English as a primary language.  In that case, no association can be fairly made about 
country of origin; one can assert either that associating with an English-based culture increases the 
likelihood of fraudulent behavior, or that English-based cultures are more vigilant in purging 
questionable studies.   
 
 1.4.1  “Would I Lie to You?” 
 A significant problem in these studies of retractions appears to be rooted in the general 
belief that the printed word is somehow inherently accurate.  For example, Decullier et al. (2013), 
in their study of retractions and conformity to COPE (Committee on Publication Ethics) 
guidelines, provided percentages per country for the “most cited reasons”.  Yet in their discussion 
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they state that the “most frequent reasons for retractions in 2008 were mistakes (28%), followed 
by plagiarism (20%) and fraud (14%)”.  Unfortunately it would be easy for readers to assume that 
somewhere in the study Decullier et al. had confirmed the retraction statement, which they hadn’t.    
 A study by Budd et al (1999) regarding citations of retracted articles displayed a bit of 
naiveté in their stated assumption: “authors are assumed to be the ones doing the retracting, 
because they would be in the position to be aware of errors or misconduct.”  In another study, 
Budd et al (1998) appeared reticent to label retractions as misconduct, choosing to do so “only if 
the statement of retraction clearly admits to wrongdoing on the part of one or more authors”.   
 Fang et al (2012) checked further into the circumstances leading to retraction notices 
attributed to error and reclassified roughly 16% of them as misconduct. 
 
 1.4.2  Is the Dataset Complete? 
 A 1980’s investigation of 135 articles by a researcher suspected of misconduct resulted in 
60 articles being deemed fraudulent or at least suspicious in quality; only 18 were retracted. 
(Couzin and Unger, 2006).  An 8 year investigation into Friedheld Herrman, a German oncologist, 
ended with only 13 of his 29 fraudulent papers retracted, six of 56 suspicious papers retracted and 
two corrections (Ibid.).  Two articles escaped retraction (as required by the ORI sanction) for 17 
years (Oransky, 2012).  Retractions do not occur for every case of misconduct.  Even when they 
do, they may not be timely or in proportion to the misconduct. 
 Determining whether a retraction is from misconduct is aggravated by variances in the 
phraseology used for each notice.  Studies of retraction and their relation to misconduct often use 
terms as “falsification” or “fabrication”, misconduct, or unethical to identify the retraction as being 
a consequence of research misconduct (Resnick and Dinse, 2013) Others avoid any reference to 
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misconduct and assign cause to error or irreproducibility (Redman et al, 2008).  Still others uses 
phraseology so obscure that it is virtually impossible to accurately assign a cause (Wager and 
Williams, 2011).   
 
1.5  A Genuine Cause for Concern 
 Highly publicized cases of fraudulent research allow for some quantification of iatrogenic 
injury to patients.  However, most cases of misconduct are not publicized and rarely are subjected 
to downstream scrutiny of potential and actual harm sustained by recipients of treatments based 
on fraudulent research. Even when the misconduct is identified before reaching manuscript phase, 
the progress in clinical trials can be thwarted by necessary efforts to unmask and repair fraudulent 
work.  One misconduct case stalled a clinical trial for two years while the records were purged of 
fraudulent data and reorganized.  (Redman, 2006.)  Worse yet, once fraudulent research results in 
a publication, it can remain unretracted for years after the misconduct is detected (Trikalinos et al., 
2008), allowing researchers to pursue invalid or even potentially harmful science.   
 Once misconduct reaches the publication phase, the risks to public health increase 
exponentially as access to fraudulent research increases.  Open access publishing, an excellent 
means of conveying sound research methodologies and theories to a greater audience, also subject 
the same audience to unsound research. A study of research articles published in open-access 
journals in 2003 found that over one-third of the articles could be located on non-journal websites 
(Wren, 2003).  The risks of the perpetuation of fraudulent research then increase, and non-journal 
websites are unlikely to receive notice of an article’s subsequent retraction or correction, whatever 
the underlying cause.   
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 Even journal websites and publication databases offer limited protection from the 
prolongation of faulty research.  Budd et al, (1999) checked citations of articles retracted during 
1966-1996 and found 2,034 post-retraction citations.  They found most citations appearing in the 
Introduction and Discussion sections and thus were most likely only used to bolster (however 
incorrectly) the research theories described in the article. Unfortunately, 154 citations were in the 
Methods section and are therefore thus quite likely to continue bad science performance. 
Improvements in technology and online access to journals hasn’t appeared to improve notification 
of fraudulent research.  Recent studies by Davis (2012) and Fang et al. (2012) show retracted 
articles continue to be cited without regard to their retraction status.  As long as fraudulent research 
practices continue undiscovered, the likelihood of it permeating through the literature remains 
ever-present. 
  
1.6 Hypothesis 
 In the late-80’s under the auspices of the Health Research Extension Act, the Office of 
Scientific Integrity and Office of Scientific Integrity Review were created. These offices were soon 
merged in to the single Office of Research Integrity (ORI). The ORI is the primary office under 
the Secretary of Health and Human Services with oversight over research and funding by the 
Public Health Service (PHS) and the National Institutes of Health (NIH); the ORI does not have 
direct oversight over the FDA, as it handles its own issues.  In keeping with its legislated function, 
the ORI investigates allegations of misconduct in research receiving NIH and PHS funding, and 
issues determinations of misconduct or closures with no misconduct findings. The ORI generally 
works in concert with the institution having oversight over the suspected fraudulent research, but 
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in cases where the institution lack suitable investigatory measures, the ORI may assume the 
primary role as investigator.   
 Once an investigation is closed, the ORI publishes a case finding.  In cases where the 
scientific or research misconduct may have affected the results in a published article, the ORI may 
(as part of a civil agreement with the Subject of the investigation) require retraction or correction 
of the affected article(s).   
 The ORI reports are more likely to provide better substantiation of misconduct related to 
the publication of articles than that of a retraction notice, especially since no standardization of 
form exists for retraction and correction notices (Davis, 2012).  Using general databases such as 
Pubmed or Medline provides no assurance that non-retracted articles are free from fraud; retraction 
and correction tallies have no guarantee of being complete or comprehensive.  Using the ORI 
misconduct findings, this study will explore the hypothesis that retractions do not accurately 
represent the incidence and prevalence of research misconduct in the biomedical, health and life 
sciences.   
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CHAPTER TWO: 
METHODS 
 
2.1 Defining Terms and Categories 
 The data for this study were chosen from ORI misconduct findings for scientific or research 
misconduct from 1993 to 2013.  To be considered “Hard” science, some type of analytical 
(objective) research method must have been the foundation for the study, such as chemical 
analyses or radiographic imaging. “Soft” sciences were considered research methods involving 
study subject recall or judgement, or any type of subjective measurement system.  Determination 
was made by the information provided in the ORI finding or by review of the referenced research 
in the finding, rather than simply categorizing by general topic area such as chemistry or 
anthropology.  For example, although social sciences may be generally considered a “soft science”, 
a study of blood chemistry levels of cortisol after witnessing an event involving serious bodily 
injury or death of another would be considered “Hard” science, provided the research misconduct 
had to do with the blood analysis and not the interview of the Subject to determine the Subject’s 
perceived level of stress.  On the other hand, a study of cancer patients’ perceived quality of life 
while undergoing different chemotherapies would be considered “soft” science, provided the 
research misconduct occurred in the surveys of patients and not in the manipulation of 
chemotherapy drug protocols.   
 Differentiation was made concerning the concept of “research” misconduct as well.  As the 
impetus for this study came from a rousing discussion of retractions due to fraudulent research in 
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laboratories, the entire research publishing process was divided into three areas:  administrative, 
research, and publishing.  Administrative misconduct was defined to involve issues dealing 
primarily with paperwork, e.g., consent forms, Institutional Review Board forms, etc.  
Inappropriate patient eligibility findings were also included in the category of “administrative 
misconduct” if the Subject was not involved in the actual analytical testing of the patients, as in 
the case of Barbara Jones, a data coordinator at St. Mary's Hospital in Montreal, Quebec who 
falsified tests for eligibility forms for two women in a breast cancer study (ORI, 1996).  Final ORI 
misconduct findings involving only administrative misconduct were not included in the dataset. 
 Misconduct events were categorized as “publishing” misconduct for instances involving 
only the production and publication of the manuscript arising from the research in question.  
Examples are plagiarism of text in published articles or when author names are added or removed 
by the Subject for their own purposes, regardless of the author’s contributions or lack thereof.   
Attempts to thwart the peer-review process, as in the case of the authors of the 60 retractions from 
the Journal of Vibration and Control (Baker, 2014), were also including under the category of 
“publishing.  Those who plagiarized but did not manipulate data were also considered under 
“publishing”, but those who plagiarized data and then manipulated it to fit their own research 
findings were considered under “research” misconduct.  Final ORI misconduct findings involving 
only publishing misconduct were not included in the dataset. 
 Misconduct events categorized as “research” misconduct were those with fabricated or 
falsified analytical or imaging test results.  Intentional modification of standard test protocols (e.g., 
changing or spiking reagents to ensure a set of desired results, changing instrument settings), 
sabotage of research of one’s own or others were also included under “research” misconduct.     
Figure 2.1 shows the decision flowchart for the selection process.   
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Figure 2.1   Flow Chart of Decision Process for Subject Selection 
 
 Review of the information provided by the ORI misconduct findings did not always 
provide clear boundaries for categorization.  While some findings were quite detailed, some 
findings were so brief that considerable effort was required to ascertain some semblance of 
understanding of the circumstances for categorization of hard research misconduct (HRM).  
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Typically, the earlier findings were quite brief, while the later findings were more detailed – but 
that was not always the case.    
 Final ORI misconduct finding for each Subject generally included the Subject’s position at 
the institution managing the NIH/PHS grants for the research, the sanctions bestowed and the 
number of years for which the sanctions apply.  Due to a lack of  standardization among institutions 
in positional responsibilities and job duties per position title, the position titles were grouped into 
general position categories (Table 2.1). 
 
Table 2.1  Position Categories and Associated Titles 
Position Category Position Title by ORI or Secondary Source 
Assistant or Associate Professor assistant professor 
associate professor 
former assistant professor 
former associate professor 
former faculty member 
former instructor 
former research assistant professor 
former research professor 
research assistant professor 
adjunct assistant professor 
Director or Department Chair clinic coordinator 
department chair 
director of the laboratory 
clinic coordinator 
Doctoral Student former visiting fellow  
former doctoral candidate 
former doctoral fellow 
former doctoral student 
doctoral student 
Graduate student former graduate student  
graduate student  
former master's degree student 
Medical Resident or Student medical student  
former MD/PhD student 
former Surgical Resident 
neurosurgical resident 
House Officer  
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Table 2.1  (Continued) 
Position Category Position Title by ORI or Secondary Source 
Postdoctoral former postdoctoral scholar, student or fellow 
former postdoctorate student or fellow 
former postdoctoral research trainee 
postdoctoral associate 
postdoctoral fellow 
former postdoctoral researcher  
former postdoctoral research associate  
postdoctoral student 
Primary researcher primary researcher 
former senior scientist 
former scientist 
former senior investigator 
principal investigator 
Professor former Professor 
Professor 
Research Associate research associate 
research fellow 
former research fellow 
former research assistant  
former research project coordinator  
former clinical research associate 
former research scientist 
former research coordinator 
former staff biochemist 
former research associate 
Technician technician 
data coordinator  
former technician 
phlebotomist 
former research technician 
staff assistant 
undergraduate student 
former laboratory technician 
 
 For the purposes of this study, an “article” was any published piece for which there was an 
author listed.  Typically, conference abstracts were not considered as “articles” unless they were 
published for public access.  In other words, abstracts published in a limited access conference 
volume were not considered as an “article”, while an abstract published in a journal special edition 
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(which would have correction or retraction notices) were considered an “article” for purposes of 
retraction or correction.      
  Again for the purposes of this study, a “retraction” was the removal, withdrawal or 
retraction of the entire article from the publishing journal.  Partial retractions, where only figures 
and/or paragraphs were designated for removal, were counted as corrections.  Corrections were 
thus considered any change to an article without the withdrawal of the entire article.   
 Those retractions and corrections where falsification or fabrication was indicated as a 
cause, using  terms such as “not authentic to original data”, or including a reference to an ORI or 
other institutional investigation were indicated as “HRM”, meaning “Hard” research misconduct.  
Retractions and corrections using terms such as “erroneous”, “not valid”, or “not accurate” were 
labeled as “Error”.  Those retraction or correction notices describing study results as “not reliable”, 
“unable to reproduce findings”, or similar terms were labeled as “NR” (for “not reproducible).  
Thus, a retraction notice (RN) where the reason for the retraction is given as “results could not be 
replicated” would be indicated in the study’s dataset as “RN NR”.  Similarly, a correction notice 
(CN) for replacement of a table due to “inaccurate data” would be indicated as “CN error” in the 
study’s dataset.  When no reason was given for the retraction or correction, or the article was 
marked as retracted but no notice could be located, or when no hard copy was available and the 
notice of retraction or correction was only found through database references, the acronym “NFI” 
(no further information) was used.  In the case of corrections for partial retractions, the notation 
“p/r” was added.   
 Table 2.2 provides an example of keywords used to categorize the Retraction and 
Correction notices.   A Notice of Concern (NOC) was noted as such in the dataset, but was counted 
under correction notices, following the same keyword categorization.  When a retraction notice 
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followed a correction notice for the same article, only the retraction notice was counted.  When a 
correction notice followed an NOC, only the correction notice was counted; for retractions 
following a correction following a notice of concern, only the retraction notice was counted.   
 
Table 2.2  Keywords for Categorizing Retractions and Correction Notice 
Category Sample Words in Retraction or Correction Notice 
HRM “not authentic”, “falsified”, “fabricated”, “misconduct”, under investigation”, 
“suspicious” 
Error “not valid”, “error”, “not accurate” 
NR “unable to replicate”, “not reliable”, “cannot reproduce”, “non-reproducible”  
p/r “partial retraction”, “only (insert phrase) is/are withdrawn/retracted/removed” 
 
2.2 Database Development 
 The datasets for this study were built from final ORI misconduct findings from 1993 
through 2013.  The final ORI misconduct findings were taken from review of ORI newsletters, 
annual reports and case studies, obtained through the ORI website http://ori.hhs.gov/.  Only 
Subjects with a standing final ORI misconduct finding were included in the dataset; Subjects 
whose findings were later overturned were not included.  Subjects who received a final ORI 
misconduct finding in the area of “hard” research misconduct (HRM) were differentiated from 
those who were found to have committed misconduct in “soft” research misconduct (SRM); only 
Subjects with HRM findings were included in the dataset.  In cases where the final ORI misconduct 
finding did not contain sufficient information as to the research area, other sources of information 
were sought (e.g., ORI website, Institutional press releases, court documents, etc.).  If no 
determination as to the research area could be made after checking other sources, then the Subject 
was excluded from the database. 
 Only Subjects whose final ORI misconduct finding met the criteria for research misconduct 
were included in the dataset.  Subjects whose final ORI misconduct finding were in research 
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misconduct as well as in administrative and/or publishing misconduct were also included in the 
dataset. In cases where the final ORI misconduct finding did not contain sufficient information as 
to the type of misconduct, other sources were sought to determine the nature of the misconduct 
(e.g., ORI website, Institutional press releases, court documents, etc.).  If no determination could 
be made after checking external sources, then the Subject was excluded from the database. 
 For each Subject included in the dataset, the Subject’s position, the institution, the sanction 
and sanction time period was recorded.  When no position title was provided in the finding, or if 
the term “employee” was used, internet sources by way of court documents, institutional press 
releases or newspaper accounts were used to identify the position held by the Subject at the time 
of the misconduct.  Only the “most advanced” position title was used in any assessments, i.e., if a 
Subject’s positions were listed as graduate student, doctoral student, and postdoctoral student, the 
position assigned to the Subject would be as a postdoctoral student.   
 Each misconduct finding was reviewed for any reference to the publishing of any article 
associated with the research in which misconduct was found.  A count was made of the number of 
published articles listed within the final ORI misconduct finding, as well as the respective journal 
name(s).  Each article referenced in a final ORI misconduct finding was checked for retraction or 
correction status by use of the following databases:  MEDLINE, PUBMED, Google Scholar, and 
the individual journal electronic database.  Notices of retraction, correction and/or concern were 
tallied per journal and Subject.  If an article was marked or stamped as “retracted” or a comment 
of “retracted” or “retraction” was made on a database, but no notice of retraction could be located, 
the article was still coded as retracted, but tagged as NFI.  Each retraction and correction notice 
was assigned according to the reason, or lack thereof, in the notice.  
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 For each Subject with a final ORI HRM misconduct finding, a database check of retracted 
and corrected articles with the Subject listed as (co)author was made.  Retracted and corrected 
articles not described or listed within the final ORI misconduct finding would be examined for 
retraction of correction cause.  Those articles that had a retraction, correction or Notice of Concern 
referencing the ORI investigation as the cause of the notice would be included in the dataset as 
part of the Subject’s total article count.  Articles retracted or corrected that did not reference the 
Subject’s final ORI misconduct finding were examined for content and timing.  If the article 
affiliated with the notice concerned research in the same subject matter and timeframe as the 
research referenced in the misconduct finding, the article was included in the dataset as part of the 
Subject’s total article count.  The journal in which the included article was published was also 
included in the dataset.  
 The 2013 five-year impact factor for each journal in which a dataset article was published 
was determined from the Journal Citation Reports® (JCR®).  Because the ORI investigations 
included published articles spanning over four decades, the choice of the 5-year impact factor 
seemed the most stable indicator for use.   
 
2.3 Statistical Analyses  
 The datasets were built using Excel 2013 spreadsheets.  Excel 2013 was also used to format 
graphs and calculate the Pearson Correlation Coefficient.  SPSS version 2.1 was used for ANOVA 
analyses.   
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CHAPTER THREE: 
RESULTS 
 
3.1 General Demographics 
 Of the 239 persons named in final ORI misconduct findings, 167 Subjects were included 
in the dataset for analyses of Hard research misconduct (Table 3.1).  The remaining Subjects (Table 
3.2) were eliminated for the misconduct having occurred in “Soft” science (n = 48) or having 
occurred in “Hard” science but only in administration or publishing areas (n = 19).  
 
Table 3.1  ORI Subjects included in HRM Dataset 
Abbs, James H Eagan, George E Horvath, Emily M London, Jill A 
Afshar, Nima Eierman, David F Huang, Chang-Fen Lorenzo, Nicholas Y 
Altman, Robert J Elton, Terry S Jacoby, David R Lowe, Patrina 
Angelides, Kimon J Fogel, Robert B Jiao, Shoushu Ma, Jian 
Apte, Aaron Fossel, Eric T Jin, Wei Manojlovic, Marija 
Arichi, Tatsumi Francis, Peter J Jorge-Rivera, Juan Carlos Marcus, Rebecca  
Arnold, Steven F French, Randall P Kammer, Gary M Matsuguchi, Tetsuya 
Aronica, Susan Friedman, Andrew Karunakaran, Thonthi Mayack, Shane 
Bartsch, Lois Ganz, Michael B Kerr, Catherine McMaster, Nicolas 
Bednarik, Daniel P Garey, Caroline E Kim, Sinae Miller, Michael W 
Bhrigu, Vipul Gelband, Craig H King, Cynthia Misra, Manoj 
Bois, Philippe Glennon, Eileen Koltover, Ilya Monte, Scott E 
Boisse-Duplan, Martin Goodwill, Meleik Kornak, Paul H Morrow, Aaron J 
Boone, James B Jr Goodwin, Elizabeth Kumar, Vipin Muchowski, Paul J 
Briggs-Brown, Nellie Grol, Jessica Lee Kurtzman, James T Muenchen, Heather J 
Brodie, Scott J Gu, Peili Langlois, Paul F Mungekar, Sagar S 
Bryant, Joy Guffee, Judy Layman, Diana Munjee, Shaan F 
Caruso, Keith A Hajra, Amitav Leadon, Steven Anthony Murillo, Carlos A 
Chang, Hung-Shu Hampton, J Keith Lee, Cathy Q Nguyen, Mai 
Cheskis, Boris Handa, Atsushi Lee, Tian-Shing Ningaraj, Nagendra S 
Constantoulakis, Pantelis Hanneken, Vickie L Leonhard, Christopher Ninnemann, John L 
Contreras, Juan Luis R Harrington, Melissa A Li, Fugang Paez, Gerardo L 
Coyle, Catherine Herman, Terence S Li, Xiaowu Paparo, Anthony A 
Daubert, Gail L  Hiserodt, John C Liburdy, Robert P Parachuri, Durga K 
Deng, Zhong Bin Ho, John L Lilly, Jason W Park, George A. 
Dreyer, Evan B Hoffmann, Bernd Lin, James C Park, Hyuk Jong 
Duan, Lingxun Horvat, Regina D Lin, Kuie-Fu (Tom) Paul, Saptarshi 
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Table 3.1  (Continued) 
Pender, Benjamin Rudick, Charles N Sotolongo, Jose R Wang, Sheng 
Poehlman, Eric T Saleh, Ayman Sperber, Kirk Washabaugh, Michael W 
Poisson, Roger Sanchez, David D Stricker, Raphael B Weiser, Weishu Y 
Portuese, Enrico Sanyak, Shamarendra Sudbø, Jon Whitters, Eric 
Prabhakaran, Kartik Sezen, Bengu Sun, Weidong Wolfort, Ryan M 
Prasad, M Renuka Shang, Xiaomin Tanner, Vivian N Woreta, Hiwot A 
Radolf, Justin Shapiro, David N Tewari, Anand Xiong, Momiao 
Ramalingam, Tirunelveli Shelley, Craig T Thiruchelvam, Mona Xu, Jianhua (James) 
Ramasubban, Sheela Shin, Junghee Thomas, Judith M Yang, Jusan 
Ravindranath, Mepur H Shishov, Michael Thwaites, Richard Yao, Zhenhai 
Reisine, Terry D Siddiqui, Farooq A Tomasula, John J Yuan, Gang 
Robinson, Clifford R Simmons, William A Tracy, Robert B Zhang, Shuang-Qing 
Rooney, John W Smart, Eric J Urban, James Zhao, Lingjie 
Roovers, Kristin Smith, Timothy R Van Parijs, Luk Zhu, Kui 
Roy, Samar N Solomon, Nicola Venters, Homer D  
 
Table 3.2 ORI Subjects not included in the HRM Database  
Abdulahi, Yahya Freisheim, James H Lieber, James David Rosales, Oscar R 
Arenburg, Deborah Gans, Joan Linn, James Gary Ruggiero, Karen M 
Arriaga, Jennifer N Geisler, Hans E Lipski, Matthew A Ryan, Celia 
August, Gerald I Goldring, Amy Beth Luce, Randall Santa Cruz, Victoria 
Berezniak, Katrina Gonzalez, Roxana Lupu, Ruth Sarker, Malabika 
Blackwell, Sheila Hartzer, Michael K Lushington, Gerald  Smith, Sherman 
Blaisdell, Jennifer Hauser, Mark McCown, William G Strout, Nancy J 
Bodily, Janell Highshaw, Ralph A Okoro, Sylvia Sultan, Ali 
Chagnon, Mark S Huelskamp, Ann Marie Padgett, David A Surprenant, Annmarie 
Clayton, Gloria Imam, S. Ashraf Palmer, Pat J Swe, April 
Conrad, Denise R Ivatt, Raymond J Pandurangi, Raghoottama S Tanaka, Kazuhiro 
Couvertier, Norma Jagannathan, Jayant Paquette, Leo A Thackeray, Robert J 
Creek, Khalilah Jones, Barbara Pennington, James C Valentin, Vilma 
deSales, Joao Carlos June, Harry L Philpot, Thomas Vardi, Danya J 
Diaz, Maria Kowalski, Mark M Qian, Jin Wanchick, Jennifer 
Edberg, Jacqueline Landay, Alan L Recknor, Karrie Weber, Scott 
Elster, Jason Leisman, Gerald Restrepo, Rocio del Carmen Woodard, Lajuane 
Farooqui, Jamal Z Li, Yi Robertson, Rashanda Zach, Calleen S 
 
 The educational status of the 167 Subjects at the time of the finding varied widely, from  
(presumably) high school education to doctorates.  Table 3.3 provides the number of Subjects per 
general educational title, the mean total retraction and correction notices and the standard deviation 
of the same.  As there were only 1 D.SC.N, 1 DVM and 2 RNs, the D.Sc.N. was grouped with 
PhDs, the DVM grouped with MDs, and the RN grouped with “No Title” for the purposes of 
statistical analyses.   
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 Table 3.3  Subjects per General Educational Title, and Mean RN/CN Counts 
General Titles 
Number of 
Subjects 
Total 
RN/CN 
Mean 
(RN/CN per 
subject) 
SD* 
No title (includes 2 RNs) 41 55 2.50 2.70 
PhD (includes 1 D. Sc. N.) 86 103 1.57 1.95 
MD (includes 1 DVM) 28 44 1.34 2.36 
Dual  12 30 1.20 3.29 
* = Standard Deviation for Mean RN/CN per Subject 
 
 Those with a doctorate comprised the greatest proportion of those with misconduct findings 
(50.9 %), followed by those without a “titled” degree (e.g., masters student, RN, undergraduate) 
at 24.6%, an M.D. or D.V.M. (16.7%) and finally those with dual terminal degrees (7.2%).  A 
statistical analysis of variance was performed (Table 3.4) showing no statistical significance to 
differences between the means of each group.   
 
Table 3.4  ANOVA of Subject Educational Title and associated RN/CN Counts 
 SS df MS F p 
Between:  34.138  3  11.379  2.098  0.103  
Within:  884.257  163  5.425    
Total:  918.395  166     
 
 The professional position (i.e. employment status) held by the Subjects ranged from the 
undefined term “employee” to Director.  Table 3.5 shows the retraction and correction notice 
counts for the Subjects assessed using the generalized position categories (as described in Table 
2.1) as well as the mean of total retraction and correction counts.   
 Keeping in mind the inadequacies of the generalization of position titles, Professors had 
the greatest mean number of retractions.  An ANOVA analysis of the number of retractions and 
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corrections in each general professional position category refuted the null hypothesis that all means 
were equivalent (Table 3.6).    
 
Table 3.5  Subjects per Position Categories, and Mean RN/CN Counts 
Position Category 
Number 
of 
Subjects 
Total 
RN/CN 
Mean 
(RN/CN per 
subject) 
SD* 
Assistant or Associate Professor  32 60 1.88 2.56 
Director or Department Chair 6 16 2.67 3.27 
Doctoral Student 9 15 1.67 1.36 
Graduate Student 16 19 1.19 1.68 
Medical Resident or Student 8 2 0.25 0.46 
Postdoctoral  38 39 1.03 1.17 
Primary Researcher 6 21 3.50 3.99 
Professor 9 44 4.89 4.99 
Research Associate 27 15 0.56 0.85 
Technician 16 1 0.06 0.25 
* = Standard Deviation for Mean RN/CN per Subject 
 
 The regression analysis of the trend line shows a weak correlation (Figure 3.1).  It thus 
appears that there was no discernable pattern relatable to position categories, although some 
categories may have had a larger or smaller proportion of retractions and corrections affiliated with 
them. 
 
Table 3.6  ANOVA of Subject Position Category and RN/CN Counts. 
 SS df MS F p 
Between:  218.045  9  24.227  5.725  0.000  
Within:  664.413  157  4.232    
Total:  882.459  166     
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Figure 3.1 Total RN/CN vs Subjects in Generalized Position Title 
 
3.2 Subjects and Associated Retractions and Corrections  
 Among the 84 final ORI misconduct findings (50.3%) had no associated articles, 24 
Subjects had ORI findings that expressly stated that no articles had been affected by the referenced 
misconduct (Table 3.7).   
 
Table 3.7  Subjects of ORI findings with No Affected Articles 
Subject Date of ORI Finding Subject 
Date of ORI 
Finding 
Apte, Aaron 3/28/1996 Harrington, Melissa A 10/23/1996 
Boone, James B Jr 2/10/1997 Karunakaran, Thonthi 7/17/2003 
Briggs-Brown, Nellie 1/25/1999 Kerr, Catherine 8/30/1995 
Caruso, Keith A 4/6/1994 King, Cynthia 4/6/1998 
Coyle, Catherine 3/27/1995 Kurtzman, James T 3/18/1995 
Daubert, Gail L  3/4/1996 Leonhard, Christopher 9/8/1997 
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Table 3.7 (Continued) 
Subject Date of ORI Finding Subject 
Date of ORI 
Finding 
Misra, Manoj 4/7/1997 Shang, Xiaomin 9/29/1997 
Munjee, Shaan F 12/17/2001 Shelley, Craig T 4/7/1993 
Portuese, Enrico 3/25/1997 Tanner, Vivian N 2/21/1995 
Ramasubban, Sheela 5/18/1993 Thwaites, Richard 10/03/1995 
Sanchez, David D 9/4/2001 Washabaugh, Michael W 5/7/1996 
Sanyak, Shamarendra  9/16/2011 Whitters, Eric 11/6/1996 
 
 
 3.2.1 ORI-Referenced Retraction and Correction Notices. 
 The remaining 83 Subjects had a total of 225 articles associated with them as referenced in 
their ORI misconduct findings.  36 Subjects (21.6 %) had one published article associated with 
misconduct, while 13 Subjects (7.8%) had 5 or more published articles associated with their 
misconduct. Table 3.8 shows article counts per ORI finding for each Subject..   
 
Table 3.8 Article Counts per ORI finding per Subject 
Name 
ORI 
Article 
#'s 
Name 
ORI 
Article 
#'s 
Name 
ORI 
Article 
#'s 
Abbs, James H 1 Murillo, Carlos A 1 Fogel, Robert B 2 
Arichi, Tatsumi 1 Prabhakaran, Kartik  1 Friedman, Andrew 2 
Arnold, Steven F 1 Prasad, M Renuka 1 Horvath, Emily M 2 
Chang, Hung-Shu 1 Rooney, John W 1 Kumar, Vipin 2 
Constantoulakis, Pantelis 1 Roy, Samar N 1 Liburdy, Robert P 2 
Deng, Zhong Bin 1 Saleh, Ayman 1 Mayack, Shane 2 
French, Randall P 1 Shapiro, David N 1 Miller, Michael W 2 
Garey, Caroline E 1 Shin, Junghee  1 Nguyen, Mai 2 
Goodwill, Meleik 1 Siddiqui, Farooq A 1 Paparo, Anthony A   2 
Handa, Atsushi 1 Smith, Timothy R 1 Ramalingam, Tirunelveli 2 
Herman, Terence S 1 Stricker, Raphael B 1 Ravindranath, Mepur H 2 
Hiserodt, John C 1 Tewari, Anand 1 Thiruchelvam, Mona 2 
Hoffmann, Bernd 1 Venters, Homer D 1 Tracy, Robert B 2 
Huang, Chang-Fen 1 Xu, Jianhua (James) 1 Urban, James 2 
Jiao, Shoushu 1 Yao, Zhenhai 1 Wang, Sheng 2 
Jorge-Rivera, Juan Carlos 1 Zhang, Shuang-Qing 1 Zhu, Kui 2 
Lee, Cathy Q 1 Aronica, Susan  2 Gu, Peili 3 
Li, Xiaowu 1 Bois, Philippe 2 Lin, Kuie-Fu (Tom) 3 
Lilly, Jason W 1 Boisse-Duplan, Martin 2 London, Jill A 3 
Matsuguchi, Tetsuya 1 Duan, Lingxun 2 Muenchen, Heather J 3 
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Table 3.8 (Continued) 
Name 
ORI 
Article 
#'s 
Name 
ORI 
Article 
#'s 
Name 
ORI 
Article 
#'s 
Paul, Saptarshi 3 Brodie, Scott J 4 Gelband, Craig H 8 
Reisine, Terry D 3 Lee, Tian-Shing 4 Leadon, Steven Anthony 8 
Roovers, Kristin 3 Angelides, Kimon J 5 Ninnemann, John L 9 
Sezen, Bengu 3 Simmons, William A 5 Poehlman, Eric T 9 
Sperber, Kirk 3 Elton, Terry S 6 Sudbø, Jon 9 
Sun, Weidong 3 Contreras, Juan Luis R 7 Smart, Eric J 10 
Weiser, Weishu Y 3 Hajra, Amitav 7 Thomas, Judith M 15 
Wolfort, Ryan M 3 Van Parijs, Luk 7   
 
 The review of MEDLINE and PUBMED databases and the Google Scholar website for 
each Subject resulted in the same 84 ORI Subjects with no articles, retraction or correction notices 
associated with the ORI-related misconduct.  The remaining 83 Subjects, however, had a total of 
231 articles associated with the ORI misconduct findings. The retractions and corrections located 
in the ORI findings and database searches for the 167 Subjects are shown in Tables 3.9 and 3.10, 
respectively.  Five of the 231 articles were not mentioned in the ORI findings, but were clearly 
related by either mention of the ORI misconduct finding in the retraction or correction notice, or 
by similarities in time and topic to other retracted or corrected articles.   
 
Table 3.9 Retraction Counts per Type per Subject 
Author RN HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
Total 
Abbs, James H 1 0 0 0 1 
Afshar, Nima 0 0 0 0 0 
Altman, Robert J 0 0 0 0 0 
Angelides, Kimon J 3 0 0 0 3 
Apte, Aaron 0 0 0 0 0 
Arichi, Tatsumi 1 0 0 0 1 
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Table 3.9 (Continued) 
Author RN HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
Total 
Arnold, Steven F 0 0 1 0 1 
Aronica, Susan  2 0 0 0 2 
Bartsch, Lois 0 0 0 0 0 
Bednarik, Daniel P 0 0 0 0 0 
Bhrigu, Vipul 0 0 0 0 0 
Bois, Philippe 0 1 0 0 1 
Boisse-Duplan, Martin 1 0 0 0 1 
Boone, James B Jr 0 0 0 0 0 
Briggs-Brown, Nellie 0 0 0 0 0 
Brodie, Scott J 2 0 0 0 2 
Bryant, Joy 0 0 0 0 0 
Caruso, Keith A 0 0 0 0 0 
Chang, Hung-Shu 1 0 0 0 1 
Cheskis, Boris 0 2 0 0 2 
Constantoulakis, Pantelis 0 0 1 0 1 
Contreras, Juan Luis R 0 6 0 0 6 
Coyle, Catherine 0 0 0 0 0 
Daubert, Gail L  0 0 0 0 0 
Deng, Zhong Bin 0 1 0 0 1 
Dreyer, Evan B 0 0 0 0 0 
Duan, Lingxun 0 1 0 0 1 
Eagan, George E 0 0 0 0 0 
Eierman, David F 0 0 0 0 0 
Elton, Terry S 2 0 3 1 6 
Fogel, Robert B 2 0 0 0 2 
Fossel, Eric T 0 0 0 0 0 
Francis, Peter J 0 0 0 0 0 
French, Randall P 0 0 0 0 0 
Friedman, Andrew 0 2 0 0 2 
Ganz, Michael B 0 0 0 0 0 
Garey, Caroline E 0 1 0 0 1 
Gelband, Craig H 1 0 0 4 5 
Glennon, Eileen 0 0 0 0 0 
Goodwill, Meleik 0 1 0 0 1 
Goodwin, Elizabeth 0 0 0 0 0 
Grol, Jessica Lee 0 0 0 0 0 
Gu, Peili 0 1 0 0 1 
Guffee, Judy 0 0 0 0 0 
Hajra, Amitav 0 2 1 0 3 
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Table 3.9 (Continued) 
Author RN HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
Total 
Hampton, J Keith  0 0 0 0 0 
Handa, Atsushi 2 0 0 0 2 
Hanneken, Vickie L 0 0 0 0 0 
Harrington, Melissa A 0 0 0 0 0 
Herman, Terence S 0 0 0 0 0 
Hiserodt, John C 0 0 0 0 0 
Ho, John L 0 0 0 0 0 
Hoffmann, Bernd 0 0 1 0 1 
Horvat, Regina D 0 0 0 0 0 
Horvath, Emily M 3 0 0 0 3 
Huang, Chang-Fen 0 0 1 1 2 
Jacoby, David R 0 0 0 0 0 
Jiao, Shoushu 0 1 0 0 1 
Jin, Wei 0 0 0 0 0 
Jorge-Rivera, Juan Carlos 1 0 0 0 1 
Kammer, Gary M 0 0 0 0 0 
Karunakaran, Thonthi 0 0 0 0 0 
Kerr, Catherine 0 0 0 0 0 
Kim, Sinae 0 0 0 0 0 
King, Cynthia 0 0 0 0 0 
Koltover, Ilya 0 0 0 0 0 
Kornak, Paul H 0 0 0 0 0 
Kumar, Vipin 0 1 1 0 2 
Kurtzman, James T 0 0 0 0 0 
Langlois, Paul F 0 0 0 0 0 
Layman, Diana 0 0 0 0 0 
Leadon, Steven Anthony 3 3 0 0 6 
Lee, Cathy Q 1 0 0 0 1 
Lee, Tian-Shing 0 1 0 1 2 
Leonhard, Christopher 0 0 0 0 0 
Li, Fugang 0 0 0 0 0 
Li, Xiaowu 1 0 0 0 1 
Liburdy, Robert P 0 0 0 0 0 
Lilly, Jason W 1 0 0 0 1 
Lin, James C 0 0 0 0 0 
Lin, Kuie-Fu (Tom) 0 0 0 0 0 
London, Jill A 1 0 0 0 1 
Lorenzo, Nicholas Y 0 0 0 0 0 
Lowe, Patrina 0 0 0 0 0 
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Table 3.9 (Continued) 
Author RN HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
Total 
Ma, Jian 0 0 0 0 0 
Manojlovic, Marija 0 0 0 0 0 
Marcus, Rebecca  0 0 0 0 0 
Matsuguchi, Tetsuya 0 0 0 0 0 
Mayack, Shane 2 0 0 0 2 
McMaster, Nicolas 0 0 0 0 0 
Miller, Michael W 3 0 0 0 3 
Misra, Manoj 0 0 0 0 0 
Monte, Scott E 0 0 0 0 0 
Morrow, Aaron J 0 0 0 0 0 
Muchowski, Paul J 0 0 0 0 0 
Muenchen, Heather J 2 0 0 1 3 
Mungekar, Sagar S 0 0 0 0 0 
Munjee, Shaan F  0 0 0 0 0 
Murillo, Carlos A 1 0 0 0 1 
Nguyen, Mai 0 0 0 1 1 
Ningaraj, Nagendra S 0 0 0 0 0 
Ninnemann, John L 0 4 0 0 4 
Paez, Gerardo L 0 0 0 0 0 
Paparo, Anthony A   0 0 0 0 0 
Parachuri, Durga K 0 0 0 0 0 
Park, George A. 0 0 0 0 0 
Park, Hyuk Jong 0 0 0 0 0 
Paul, Saptarshi 0 3 0 0 3 
Pender, Benjamin 0 0 0 0 0 
Poehlman, Eric T 6 0 0 0 6 
Poisson, Roger 0 0 0 0 0 
Portuese, Enrico 0 0 0 0 0 
Prabhakaran, Kartik  0 0 1 0 1 
Prasad, M Renuka 1 0 0 0 1 
Radolf, Justin  0 0 0 0 0 
Ramalingam, Tirunelveli 0 1 1 0 2 
Ramasubban, Sheela 0 0 0 0 0 
Ravindranath, Mepur H 0 0 0 0 0 
Reisine, Terry D 0 0 0 0 0 
Robinson, Clifford R 0 0 0 0 0 
Rooney, John W 0 0 1 0 1 
Roovers, Kristin 0 2 0 0 2 
Roy, Samar N 0 0 1 0 1 
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Table 3.9 (Continued) 
Author RN HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
Total 
Rudick, Charles N 0 0 0 0 0 
Saleh, Ayman 0 0 0 0 0 
Sanchez, David D 0 0 0 0 0 
Sanyak, Shamarendra  0 0 0 0 0 
Sezen, Bengu 0 0 6 0 6 
Shang, Xiaomin 0 0 0 0 0 
Shapiro, David N 0 0 0 0 0 
Shelley, Craig T 0 0 0 0 0 
Shin, Junghee  0 1 0 0 1 
Shishov, Michael 0 0 0 0 0 
Siddiqui, Farooq A 0 0 0 0 0 
Simmons, William A 0 0 4 0 4 
Smart, Eric J 10 0 0 0 10 
Smith, Timothy R 1 0 0 0 1 
Solomon, Nicola 0 0 0 0 0 
Sotolongo, Jose R 1 0 0 0 1 
Sperber, Kirk 0 3 0 0 3 
Stricker, Raphael B 1 0 0 0 1 
Sudbø, Jon 9 0 0 0 9 
Sun, Weidong 0 0 2 0 2 
Tanner, Vivian N 0 0 0 0 0 
Tewari, Anand 0 1 0 0 1 
Thiruchelvam, Mona 1 0 0 1 2 
Thomas, Judith M 0 11 0 1 12 
Thwaites, Richard 0 0 0 0 0 
Tomasula, John J 1 0 0 0 1 
Tracy, Robert B 2 0 0 0 2 
Urban, James 0 1 0 0 1 
Van Parijs, Luk 4 1 0 0 5 
Venters, Homer D 0 0 0 0 0 
Wang, Sheng 1 1 0 0 2 
Washabaugh, Michael W 0 0 0 0 0 
Weiser, Weishu Y 3 1 0 0 4 
Whitters, Eric 0 0 0 0 0 
Wolfort, Ryan M 0 0 0 0 0 
Woreta, Hiwot A 0 0 0 0 0 
Xiong, Momiao 0 0 0 0 0 
Xu, Jianhua (James) 1 0 0 0 1 
Yang, Jusan 0 0 0 0 0 
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Table 3.9 (Continued) 
Author RN HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
Total 
Yao, Zhenhai 0 0 0 1 1 
Yuan, Gang 0 0 0 0 0 
Zhang, Shuang-Qing 0 0 0 1 1 
Zhao, Lingjie 0 0 0 0 0 
Zhu, Kui 1 0 1 1 3 
Totals 80 54 26 14 174 
 
Table 3.10  Correction Counts per Type per Subject 
Author CN HRM 
CN 
Error 
CN 
NR 
CN 
NFI 
Total 
Abbs, James H 0 0 0 0 0 
Afshar, Nima 0 0 0 0 0 
Altman, Robert J 0 0 0 0 0 
Angelides, Kimon J 0 0 0 0 0 
Apte, Aaron 0 0 0 0 0 
Arichi, Tatsumi 0 1 0 0 1 
Arnold, Steven F 0 0 0 0 0 
Aronica, Susan  0 0 0 0 0 
Bartsch, Lois 0 0 0 0 0 
Bednarik, Daniel P 0 0 0 0 0 
Bhrigu, Vipul 0 0 0 0 0 
Bois, Philippe 0 1 0 0 1 
Boisse-Duplan, Martin 0 0 0 0 0 
Boone, James B Jr 0 0 0 0 0 
Briggs-Brown, Nellie 0 0 0 0 0 
Brodie, Scott J 2 0 0 0 2 
Bryant, Joy 0 0 0 0 0 
Caruso, Keith A 0 0 0 0 0 
Chang, Hung-Shu 0 0 0 0 0 
Cheskis, Boris 0 0 0 0 0 
Constantoulakis, Pantelis 0 0 0 0 0 
Contreras, Juan Luis R 0 0 0 1 1 
Coyle, Catherine 0 0 0 0 0 
Daubert, Gail L  0 0 0 0 0 
Deng, Zhong Bin 0 0 0 0 0 
Dreyer, Evan B 0 0 0 0 0 
Duan, Lingxun 0 5 0 0 5 
Eagan, George E 0 0 0 0 0 
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Table 3.10 (Continued) 
Author CN HRM 
CN 
Error 
CN 
NR 
CN 
NFI 
Total 
Eierman, David F 0 0 0 0 0 
Elton, Terry S 0 0 0 0 0 
Fogel, Robert B 0 0 0 0 0 
Fossel, Eric T 0 0 0 0 0 
Francis, Peter J 0 0 0 0 0 
French, Randall P 0 1 0 0 1 
Friedman, Andrew 0 0 0 0 0 
Ganz, Michael B 0 0 0 0 0 
Garey, Caroline E 0 0 0 0 0 
Gelband, Craig H 3 0 0 0 3 
Glennon, Eileen 0 0 0 0 0 
Goodwill, Meleik 0 0 0 0 0 
Goodwin, Elizabeth 0 0 0 0 0 
Grol, Jessica Lee 0 0 0 0 0 
Gu, Peili 0 1 0 0 1 
Guffee, Judy 0 0 0 0 0 
Hajra, Amitav 0 2 1 0 3 
Hampton, J Keith  0 0 0 0 0 
Handa, Atsushi 0 0 0 0 0 
Hanneken, Vickie L 0 0 0 0 0 
Harrington, Melissa A 0 0 0 0 0 
Herman, Terence S 0 1 0 0 1 
Hiserodt, John C 1 0 0 0 1 
Ho, John L 0 0 0 0 0 
Hoffmann, Bernd 0 0 0 0 0 
Horvat, Regina D 0 0 0 0 0 
Horvath, Emily M 0 0 0 0 0 
Huang, Chang-Fen 0 0 0 0 0 
Jacoby, David R 0 0 0 0 0 
Jiao, Shoushu 0 0 0 0 0 
Jin, Wei 0 0 0 0 0 
Jorge-Rivera, Juan Carlos 0 0 0 0 0 
Kammer, Gary M 0 0 0 0 0 
Karunakaran, Thonthi 0 0 0 0 0 
Kerr, Catherine 0 0 0 0 0 
Kim, Sinae 0 0 0 0 0 
King, Cynthia 0 0 0 0 0 
Koltover, Ilya 0 0 0 0 0 
Kornak, Paul H 0 0 0 0 0 
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Table 3.10 (Continued) 
Author CN HRM 
CN 
Error 
CN 
NR 
CN 
NFI 
Total 
Kumar, Vipin 0 0 0 0 0 
Kurtzman, James T 0 0 0 0 0 
Langlois, Paul F 0 0 0 0 0 
Layman, Diana 0 0 0 0 0 
Leadon, Steven Anthony 0 0 2 0 2 
Lee, Cathy Q 0 0 0 0 0 
Lee, Tian-Shing 0 2 0 0 2 
Leonhard, Christopher 0 0 0 0 0 
Li, Fugang 0 0 0 0 0 
Li, Xiaowu 0 0 0 0 0 
Liburdy, Robert P 1 0 0 0 1 
Lilly, Jason W 0 0 0 0 0 
Lin, James C 0 0 0 0 0 
Lin, Kuie-Fu (Tom) 1 0 0 2 3 
London, Jill A 0 0 0 1 1 
Lorenzo, Nicholas Y 0 0 0 0 0 
Lowe, Patrina 0 0 0 0 0 
Ma, Jian 0 0 0 0 0 
Manojlovic, Marija 0 0 0 0 0 
Marcus, Rebecca  0 0 0 0 0 
Matsuguchi, Tetsuya 1 0 0 0 1 
Mayack, Shane 0 0 0 0 0 
McMaster, Nicolas 0 0 0 0 0 
Miller, Michael W 0 0 0 0 0 
Misra, Manoj 0 0 0 0 0 
Monte, Scott E 0 0 0 0 0 
Morrow, Aaron J 0 0 0 0 0 
Muchowski, Paul J 0 0 0 0 0 
Muenchen, Heather J 0 0 0 0 0 
Mungekar, Sagar S 0 0 0 0 0 
Munjee, Shaan F  0 0 0 0 0 
Murillo, Carlos A 0 0 0 0 0 
Nguyen, Mai 0 1 0 0 1 
Ningaraj, Nagendra S 0 0 0 0 0 
Ninnemann, John L 0 4 0 0 4 
Paez, Gerardo L 0 0 0 0 0 
Paparo, Anthony A   0 0 0 0 0 
Parachuri, Durga K 0 0 0 0 0 
Park, George A. 0 0 0 0 0 
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Table 3.10 (Continued) 
Author CN HRM 
CN 
Error 
CN 
NR 
CN 
NFI 
Total 
Park, Hyuk Jong 0 0 0 0 0 
Paul, Saptarshi 0 1 0 0 1 
Pender, Benjamin 0 0 0 0 0 
Poehlman, Eric T 3 0 0 0 3 
Poisson, Roger 0 0 0 0 0 
Portuese, Enrico 0 0 0 0 0 
Prabhakaran, Kartik  0 0 0 0 0 
Prasad, M Renuka 0 0 0 0 0 
Radolf, Justin  0 0 0 0 0 
Ramalingam, Tirunelveli 0 0 0 0 0 
Ramasubban, Sheela 0 0 0 0 0 
Ravindranath, Mepur H 0 1 0 0 1 
Reisine, Terry D 0 3 0 0 3 
Robinson, Clifford R 0 0 0 0 0 
Rooney, John W 0 0 0 0 0 
Roovers, Kristin 0 1 0 0 1 
Roy, Samar N 0 0 0 0 0 
Rudick, Charles N 0 0 0 0 0 
Saleh, Ayman 0 1 0 0 1 
Sanchez, David D 0 0 0 0 0 
Sanyak, Shamarendra  0 0 0 0 0 
Sezen, Bengu 0 0 0 0 0 
Shang, Xiaomin 0 0 0 0 0 
Shapiro, David N 0 1 0 0 1 
Shelley, Craig T 0 0 0 0 0 
Shin, Junghee  0 0 0 0 0 
Shishov, Michael 0 0 0 0 0 
Siddiqui, Farooq A 0 0 0 0 0 
Simmons, William A 0 1 0 0 1 
Smart, Eric J 0 0 0 0 0 
Smith, Timothy R 0 0 0 0 0 
Solomon, Nicola 0 0 0 0 0 
Sotolongo, Jose R 0 0 0 0 0 
Sperber, Kirk 0 2 0 0 2 
Stricker, Raphael B 0 0 0 0 0 
Sudbø, Jon 0 0 0 0 0 
Sun, Weidong 0 0 0 0 0 
Tanner, Vivian N 0 0 0 0 0 
Tewari, Anand 0 1 0 0 1 
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Table 3.10 (Continued) 
Author CN HRM 
CN 
Error 
CN 
NR 
CN 
NFI 
Total 
Thiruchelvam, Mona 0 0 0 0 0 
Thomas, Judith M 0 2 0 0 2 
Thwaites, Richard 0 0 0 0 0 
Tomasula, John J 0 0 0 0 0 
Tracy, Robert B 0 0 0 0 0 
Urban, James 0 0 0 0 0 
Van Parijs, Luk 2 1 0 1 4 
Venters, Homer D 0 1 0 0 1 
Wang, Sheng 0 0 0 0 0 
Washabaugh, Michael W 0 0 0 0 0 
Weiser, Weishu Y 0 0 0 0 0 
Whitters, Eric 0 0 0 0 0 
Wolfort, Ryan M 0 0 0 0 0 
Woreta, Hiwot A 0 0 0 0 0 
Xiong, Momiao 0 0 0 0 0 
Xu, Jianhua (James) 0 0 0 0 0 
Yang, Jusan 0 0 0 0 0 
Yao, Zhenhai 0 0 0 0 0 
Yuan, Gang 0 0 0 0 0 
Zhang, Shuang-Qing 0 0 0 0 0 
Zhao, Lingjie 0 0 0 0 0 
Zhu, Kui 0 0 0 0 0 
Totals 14 35 3 5 57 
 
 
 Of these 83 Subjects, 51 Subjects (30.5% of the total Subject dataset) had only retraction 
notices, 11 Subjects (6.59% of the total Subject dataset) had only correction notices, and 21 
Subjects (12.6% of the total Subject dataset) had both retraction and correction notices.  Overall, 
roughly 56.9% of those with misconduct findings had no retraction notices associated with their 
misconduct, while 43.1% of the Subjects had at least one retraction associated with their 
misconduct. In examining the separate categories for retraction and correction notices, 80 (46%) 
of the 174 retraction notices indicated research misconduct as the reason for the retraction, while 
54 retraction notices (31%) were attributed to some type of error, either in research methods or 
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data analysis.  Of the 57 correction notices, 14 (24.6%) were attributed to research misconduct, 
while 35 (61.4%) correction notices were attributed to error.  Altogether, only 94 (40.7%) of the 
notices arising from an official finding of misconduct gave misconduct as a foundation for article 
retraction or correction.   Figure 3.2 displays a bar graph showing the number of Subjects per total 
number of retractions and corrections combined.  Figures 3.3 through 3.7 compare the number of 
retractions and corrections per type of notice.   
 
 
Figure 3.2  Number of Subjects per Total Retraction and Correction Counts 
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Figure 3.3  Number of Subjects per Total HRM Retraction and HRM Correction Counts 
 
Figure 3.4  Number of Subjects per HRM Retraction and HRM Correction Counts 
 37 
 
 
Figure 3.5  Number of Subjects per Error Retraction and Error Correction Counts 
 
 
 
Figure 3.6  Number of Subjects per NR Retraction and NR Correction Counts 
 38 
 
 
Figure 3.7  Number of Subjects per NFI Retraction and NFI Correction Counts 
 
 The total number of retractions and corrections was plotted against the year of ORI finding 
(Figure 3.8), as was the total number of retractions only (Figure 3.9). 
 
 
Figure 3.8 Total Number of RNs and CNs per Year of ORI Finding 
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Figure 3.9 Total Number of RNs per Year of ORI Finding 
 
 3.2.2 Non-ORI-Referenced Articles with Retraction or Correction Notices 
 The five articles not mentioned in the ORI findings demonstrated a relation to the 
misconduct finding by either mention of the ORI misconduct finding in the retraction or correction 
notice or by similarities in time and topic to other retracted or corrected articles.  The retraction 
and correction notices were included in total counts, but any statistical analyses of the retractions 
and corrections as an isolated category would be of no value as sample size is too small.  No 
retraction or correction notice of any kind could be located for 13 articles identified within the ORI 
misconduct findings (Table 3.11)   
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Table 3.11 Non-ORI-Referenced with Retraction or Correction Notices 
Subject 
(Year of 
Finding) 
Article RN or CN 
Elton, Terry S 
(2013) 
Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, 
Elton TS. 2006. MicroRNA-155 regulates human 
angiotensin II type 1 receptor expression in fibroblasts. 
The Journal of Biological Chemistry. 281(27), 18277-84. 
RN NFI.  2013. J 
Biol Chem. 288(6): 
226 
Horvath, 
Emily (2010) 
Horvath EM, Tackett L, Elmendorf JS. 2008. A novel 
membrane-based anti-diabetic action of atorvastatin. 
Biochemical and Biophysical Research Communications. 
372(4):639-43. 
RN HRM.  2010.  
Biochemical and 
Biophysical 
Research 
Communications. 
401 (2): 319 
van, Parijs, 
Luk (2008) 
1.  Refaeli Y, van Parijs L,  Stephen I. Alexander SI, 
Abbas AK. 2002. Interferon γ is required for activation-
induced death of T lymphocytes. Journal of  Experimental 
Medicine. 196(7):999–1005. 
 
2. Kelly E, Won A, Refaeli Y, van Parijs L. 2002. IL-2 and 
related cytokines can promote T cell survival by activating 
AKT. Journal of Immunology. 168(2):597-603. 
1. CN Error.  2012.  
Journal of 
Experimental 
Medicine. 209(5): 
1049 
 
 
2.  CN p/r HRM.  
2007. Journal of 
Immunology. 
179(12): 8569. 
Weiser, 
Weishu 
(1995) 
Orme I M, Furney SK, Skinner PS, Roberts AD, Brennan 
PJ, Russell DG, Shiratsuchi H, Ellner JJ, Weiser WY. 
1993. Inhibition of growth of Mycobacterium avium in 
murine and human mononuclear phagocytes by migration 
inhibitory factor. Infection and immunity 61(1):338-342. 
RN Error:  1994, 
Infection and 
Immunity.  62 (5): 
2141.  Related by 
topic and time 
 
 3.2.3 ORI-Referenced Articles with No Retractions or Corrections 
 No retraction or correction notice of any kind could be located for 13 articles identified 
within the ORI misconduct findings (Table 3.12)     
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Table 3.12  Subjects with Articles Referenced in ORI finding with no known RN or CN 
Subject 
(Year of 
Finding) 
Publication with no located RN or CN 
Total 
(located) 
RN/CN for 
Subject 
Angelides, 
Kimon J 
(1999) 
1) Black JA, Friedman B, Waxman SG, Elmer LW, Angelides 
KJ. 1989.  Immuno-ultrastructural localization of sodium 
channels at nodes of Ranvier and perinodal astrocytes in rat 
optic nerve. Proc. R. Soc. London  B. 238:39-51.  
 
2) Minturn JE, Sontheimer H, Black JA, Angelides KJ, 
Ransom BR, Ritchie JM, Waxman SG. 1991. Membrane-
associated sodium channels and cytoplasmic precursors in 
glial cells.  Ann. N.Y. Acad. Sci. 633:255-271. 
3 
Elton, Terry S  
(2012) 
Martin MM, Buckenberger JA, Knoell DL, Strauch AR, Elton 
TS. 2006.  TGF-beta(1) regulation of human AT1 receptor 
mRNA splice variants harboring exon 2. Mol Cell Endocrinol 
249(1-2):21-31. 
6 
Gu, Peili 
(2008) 
Gu P, LeMenuet D, Chung A, Cooney AJ. 2006. Differential 
Recruitment of Methylated CpG Binding Domains [MBDs] 
by the Orphan Receptor GCNF Initiates the Repression and 
Silencing of Oct4 Expression.  Mol. Cell. Biology. 
26(24):9471-9483. 
2 
Liburdy, 
Robert P 
(1999) 
Liburdy, RP.  1992.  Biological interactions of cellular 
systems with time-varying magnetic fields.  Ann. N.Y. Acad. 
Sci.  649:74-95.  
1 
Nguyen, Mai 
(2008) 
Liu Y, Wang JL, Chang H, Barsky SH, Nguyen M. 2000.  
Breast-cancer diagnosis with nipple fluid bFGF. The Lancet. 
356:567-569. 
2 
Ninnemann, 
John L (1994) 
Ninnemann JL, Stockland AE, Condie JT. 1983. Induction of 
prostaglandin synthesis-dependent suppressor cells with 
endotoxin: occurrence in patients with thermal injuries. 
Journal of Clinical Immunology. 3(2):142-50. 
8 
Paparo, 
Anthony A  
(1993) 
1) Paparo AA, Murphy JA. 1975. The effect of STH on the 
SEM and frequency response of the branchial nerve in Mytilus 
edulis as it relates to ciliary activity. Comparative 
Biochemistry and Physiology. C: Comparative 
Pharmacology. 51(2):165-7. 
 
2) Paparo AA, Murphy JA. 1975. The effect of STH and 6-
OH-dopa on the SEM of the branchial nerve and visceral 
ganglion of the bivalve Elliptio complanata as it relates to 
ciliary activity. Comparative Biochemistry and Physiology. 
C: Comparative Pharmacology. 51(2):169-70. 
0 
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Table 3.12 (Continued) 
Subject 
(Year of 
Finding) 
Publication with no located RN or CN 
Total 
(located) 
RN/CN for 
Subject 
Ravindranath, 
Mepur H 
(2012) 
Ravindranath MH, Yesowitch P, Sumobay C, Morton DL. 
2007. Glycoimmunomics of human cancer: Current concepts 
and future perspectives. Future Oncology 3(2):201-214. 
1 
Shapiro, David 
N (1997) 
Sublett JE, Jeon IS, Shapiro DN. 1995. The aveolar 
rhabdomyosarcoma PAX3/FKHR fusion protein is a 
transcriptional activator.  Oncogene 11:545-552.    
1 
Sun, Weidong 
(1997) 
Sun W, Chen X, Chantler PD. 1994. Inhibition of 
neuritogenesis by antisense arrest of the expression of a 
specific isoform of brain myosin II.  Journal of Muscle 
Research and Cell Motility 15:184-185.  
2 
Urban, James 
(1995) 
Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, 
Clayton J, Ando DG, Sercarz EE, Hood L. 1988.  Restricted 
use of T cell receptor V genes in murine autoimmune 
encephalomyelitis raises possibilities for antibody therapy. 
Cell. 54(4):577–592. 
1 
 
 
3.3 Journals and Retraction and Correction Notices 
 Over 100 journals were associated with publishing the articles referenced in and related to 
the ORI misconduct findings. Of the 100 journals in which either retractions or corrections were 
published, 18 journals (18%) had no published retraction notices and 64 journals (64%) had no 
published corrections.  49 journals (49%) had only one retraction published while 36 journals 
(36%) had only one published correction.  Looking at the combination of total counts of retraction 
and correction notices (Table 3.13), roughly three-quarters of the journals had published only one 
or two articles that were retracted or corrected for misconduct.  Only three journals had totals 
greater than10 misconduct-associated retractions and corrections:  PNAS, Journal of Immunology, 
and Journal of Biological Chemistry.  
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Table 3.13 Journals and Related Retraction and Correction Counts 
Journal 
RN 
HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
CN 
HRM 
CN 
Error 
CN 
NFI 
CN 
NR 
Totals 
Acta Obstetricia et 
Gynecologica 
Scandinavica 
1 0 0 0 0 0 0 0 1 
American Journal of 
Pathology 
0 0 0 0 1 0 0 0 1 
American Journal of 
Physiology - 
Endocrinology and 
Metabolism 
0 0 0 0 1 0 0 0 1 
American Journal of 
Physiology -Lung cellular 
and molecular physiology 
0 0 1 0 0 0 0 0 1 
American Journal of 
Physiology: Cellular 
Physiology 
3 0 0 0 0 0 0 0 3 
Annals of Internal 
Medicine 
1 0 0 0 0 0 0 0 1 
Biochemical and 
Biophysical Research 
Communications 
1 1 2 0 0 0 0 0 4 
Biochemistry 0 2 0 0 0 1 0 0 3 
Biochimica et Biophysica 
Acta 
0 0 1 1 0 0 0 0 2 
Biomedical 
Chromatography 
0 0 0 1 0 0 0 0 1 
Blood 2 0 0 0 0 1 0 0 3 
Brain Research 2 0 0 0 0 0 1 0 3 
Cancer Research 0 1 0 0 0 0 0 0 1 
Carcinogenesis 1 0 0 0 0 0 0 0 1 
Cell 0 2 0 0 0 0 0 0 2 
Cellular Immunity 0 1 0 0 0 0 0 0 1 
Chemical Senses 1 0 0 0 0 0 0 0 1 
Circulation Research 0 0 0 0 2 0 0 0 2 
Clinical Cancer Research 1 0 0 1 0 0 0 0 2 
Clinical Medicine & 
Research 
1 0 0 0 0 0 0 0 1 
Coronary Artery Disease 0 0 0 0 1 0 0 0 1 
Current Opinion in 
Investigational Drugs 
0 0 0 1 0 0 0 0 1 
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Table 3.13 (Continued) 
Journal 
RN 
HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
CN 
HRM 
CN 
Error 
CN 
NFI 
CN 
NR 
Totals 
Current Opinion in 
Molecular Therapeutics 
0 0 0 0 0 0 1 0 1 
Current Opinion in Organ 
Transplantation 
0 0 0 0 0 2 1 0 3 
Developmental Biology 0 0 0 0 0 1 0 0 1 
Developmental Cell 0 1 0 0 0 0 0 0 1 
Developmental 
Neuroscience 
1 0 0 0 0 0 0 0 1 
Diabetes 0 0 0 1 0 0 0 0 1 
Diabetes and Metabolism 1 0 0 0 0 0 0 0 1 
EMBO Journal 2 1 0 0 1 0 0 0 4 
Endocrinology 2 0 0 0 0 0 0 0 2 
Environmental Health 
Perspectives 
1 0 0 0 0 0 0 0 1 
European Journal of 
Clinical Investigation 
1 0 0 0 0 0 0 0 1 
FEBS Letters 0 0 0 1 1 0 0 0 2 
Fertility and Sterility 0 1 0 0 0 0 0 0 1 
Gastroenterology 1 0 0 0 0 0 0 0 1 
Genes & Development 0 0 1 0 0 0 0 0 1 
Genes, Chromosomes & 
Cancer 
0 0 0 0 0 0 0 1 1 
Genomics 0 1 0 0 0 0 0 0 1 
Glia 1 0 0 0 0 0 0 0 1 
Graft 0 2 0 0 0 0 0 0 2 
Human Gene Therapy 0 0 0 0 0 0 1 0 1 
Human Immunology 0 1 0 0 0 0 0 0 1 
Hypertension 0 0 0 3 2 0 0 0 5 
Hypertension Research 0 0 0 0 0 0 1 0 1 
Immunity 4 0 2 0 0 0 0 0 6 
Immunogenetics 0 0 1 0 0 0 0 0 1 
Immunological Reviews 0 1 0 0 0 0 0 0 1 
Immunology Letters 0 0 0 0 0 1 0 0 1 
Immunology Research 0 1 0 0 0 0 0 0 1 
Infection and Immunity 0 2 0 0 0 0 0 0 2 
International Journal of 
Cancer 
0 0 0 0 0 1 0 0 1 
International Journal of 
Radiation Oncology 
Biology Physics 
0 0 0 0 0 1 0 0 1 
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Table 3.13 (Continued) 
Journal 
RN 
HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
CN 
HRM 
CN 
Error 
CN 
NFI 
CN 
NR 
Totals 
Journal of American 
Chemical Society 
0 0 6 0 0 0 0 0 6 
Journal of Applied 
Physiology 
1 0 0 0 0 0 0 0 1 
Journal of Biological 
Chemistry 
10 0 2 5 0 2 0 0 19 
Journal of Bone and 
Mineral Research 
1 0 0 0 0 0 0 0 1 
Journal of Cell Biology 0 1 0 0 0 0 0 0 1 
Journal of Clinical 
Investigation 
1 0 0 0 0 1 0 0 2 
Journal of Experimental 
Medicine 
0 2 0 0 0 2 0 0 4 
Journal of General 
Virology 
1 0 0 0 0 0 0 0 1 
Journal of Immunology 2 5 2 0 2 4 0 0 15 
Journal of Infectious 
Diseases 
0 0 0 0 1 0 0 0 1 
Journal of Leukocyte 
Biology 
1 0 0 0 0 0 0 0 1 
Journal of Lipid Research 1 0 0 0 0 0 0 0 1 
Journal of Molecular and 
Cellular Cardiology 
0 0 0 1 0 0 0 0 1 
Journal of Molecular 
Biology 
0 0 1 0 0 0 0 0 1 
Journal of Neurochemistry 1 0 0 0 0 0 0 0 1 
Journal of 
Neuroimmunology 
0 1 0 0 0 0 0 0 1 
Journal of 
Neurophysiology 
1 0 0 0 0 0 0 0 1 
Journal of Neuroscience 1 0 0 0 0 0 0 0 1 
Journal of Pathology 1 0 0 0 0 0 0 0 1 
Journal of Pharmacology 
and Experimental 
Therapeutics 
0 0 0 0 0 1 0 0 1 
Journal of Trauma 0 3 0 0 0 3 0 0 6 
Journal of Urology 2 0 0 0 0 0 0 0 2 
Journal of Virology 0 0 0 0 0 5 0 0 5 
Lancet 1 1 0 0 0 1 0 0 3 
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Table 3.13 (Continued) 
Journal 
RN 
HRM 
RN 
Error 
RN    
NR 
RN 
NFI 
CN 
HRM 
CN 
Error 
CN 
NFI 
CN 
NR 
Totals 
Metabolism Clinical and 
Experimental 
1 0 0 0 0 0 0 0 1 
Molecular and Cellular 
Biology 
1 4 0 0 0 1 0 1 7 
Molecular Endocrinology 1 0 0 0 0 0 0 0 1 
Molecular Pharmacology 0 0 0 0 0 1 0 0 1 
Mutation Research/DNA 
Repair 
1 1 0 0 0 0 0 0 2 
Nature 1 1 0 0 0 1 0 0 3 
Nature Cell Biology 1 0 1 0 0 1 0 0 3 
Nature Genetics 0 1 0 0 1 0 0 0 2 
Nature Medicine 0 1 0 0 0 0 0 0 1 
Neurology 1 0 0 0 0 0 0 0 1 
Neuron 0 0 1 0 0 0 0 0 1 
New England Journal of 
Medicine 
3 0 0 0 0 0 0 0 3 
Obesity Research 0 0 0 0 1 0 0 0 1 
Obstetrics and Gynecology 0 1 0 0 0 0 0 0 1 
Oncogene 0 1 0 0 0 0 0 0 1 
Oral Oncology 4 0 0 0 0 0 0 0 4 
Plant Cell 1 0 0 0 0 0 0 0 1 
PNAS 5 3 2 0 1 2 0 1 14 
Science 3 0 3 0 0 1 0 0 7 
Sleep 2 0 0 0 0 0 0 0 2 
Transplant Immunity 0 2 0 0 0 0 0 0 2 
Transplantation 0 8 0 0 0 0 0 0 8 
Urology 1 0 0 0 0 0 0 0 1 
Totals 79 54 26 15 15 34 5 3 231 
 
 Looking at the journal section heading for each retraction or correction notice, there were 
39 different section headings for the notices.  For the most part, the section heading directly related 
to the action taken (e.g., a correction notice under a “Corrections” heading of some type, a 
retraction notice under a “Retraction” notice of some type).  However, 20 retraction notices were 
located under the section heading “Additions and Corrections” and 14 retraction notices were 
under “Corrections” or “Erratum”.  Under the heading of “Letters” or “Letters to the Editor”, 12 
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retractions and 8 corrections were published.  Under “Retractions” or similar headings, 12 
correction notices involving partial retractions were published.  No information on section 
headings was available for 12 retractions or corrections.  Thus, roughly 34% of the notices 
published under section headings differed from the headings’ indicated purpose.  Table 4.14 shows 
the section headings for the notices published for all Subjects.   
 
Table 3.14 Section Heading for Notices in Journals 
ACTION SECTION HEADING 
# OF NOTICES PER 
GROUP 
CN ERROR Additions and Corrections 1 
RN NFI Additions and Corrections 1 
RN NR Additions and Corrections 7 
RN HRM Additions and Corrections 10 
RN HRM Announcement: Notice of Retraction 1 
CN ERROR Author's Correction 6 
RN NR Clarification and Retraction 1 
CN NR Correction 1 
RN HRM Correction 1 
CN ERROR Correction 5 
RN HRM Correction and Retractions: Retractions 1 
CN ERROR Corrections 6 
RN HRM Corrections and Amendments 1 
CN P/R ERROR Corrections and Retraction 1 
RN ERROR Corrections and Retraction 1 
RN ERROR Corrections and Retraction: Retraction 1 
RN HRM Corrections and Retraction: Retraction 1 
CN P/R ERROR Correspondence 1 
RN ERROR Corrigenda and Retraction: Retraction 1 
CN ERROR Corrigenda: Corrigendum 1 
CN ERROR Corrigendum 1 
CN HRM Corrigendum 1 
CN P/R HRM Corrigendum 3 
CN AUTHOR 
NAME 
Department of Error 1 
CN P/R HRM Erratum 1 
RN HRM Erratum 1 
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Table 3.14 (Continued) 
ACTION SECTION HEADING 
# OF NOTICES PER 
GROUP 
RN NFI Erratum 1 
RN NR Erratum 1 
RN ERROR Erratum 2 
CN ERROR Erratum 5 
CN HRM Letter 1 
RN HRM Letter of Retraction 2 
RN NR Letter of Retraction 2 
RN ERROR Letter of Retraction 4 
CN HRM Letter to the Editor 1 
RN HRM Letter to the Editor  1 
RN HRM Letter to the Editor: Retraction of 
publication 
1 
RN ERROR Letter: Retraction 1 
RN NR Letters 1 
CN ERROR Letters to Nature: Correction 1 
CN HRM Letters to the Editor 1 
CN ERROR Letters to the Editor 3 
RN ERROR Letters to the Editor 3 
RN ERROR Letters to the Editor: Retraction 1 
RN HRM Letters: Notice of Retraction 1 
RN HRM Letters: Retraction 2 
RN NR Letters: Retraction 2 
CN ERROR Letters: Sequence Correction 1 
RN ERROR NFI 2 
CN NFI NFI 4 
RN NFI NFI 6 
NOC HRM Note of Concern 1 
RN ERROR Notice of Retraction 1 
RN HRM Notice of Retraction 2 
CN P/R NFI Partial Retractions 1 
CN P/R ERROR Partial Retractions 2 
RN  NR Retraction 1 
CN P/R ERROR Retraction 2 
CN P/R NR Retraction 2 
RN HRM Retraction  2 
CN P/R HRM Retraction 3 
RN NFI Retraction 5 
RN NR Retraction 9 
RN ERROR Retraction 68 
RN ERROR Retraction and Correction 1 
RN HRM Retraction and Correction: Retraction 1 
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Table 3.14 (Continued) 
ACTION SECTION HEADING 
# OF NOTICES PER 
GROUP 
CN P/R HRM Retraction and Corrections: Retraction 1 
RN NR Retraction Notice 1 
RN ERROR Retraction Notice 3 
RN HRM Retraction Notice 5 
RN HRM Retraction Statement 1 
CN P/R HRM Retractions 1 
RN NR Retractions 1 
RN ERROR Retractions 2 
RN HRM Retractions 5 
 
 The 5-year impact factors and number of retraction and correction notices are shown in 
Table 3.15.  The 5-year impact factors ranged from 52.426 (New England Journal of Medicine) to 
1.286 (Coronary Artery Disease).  Figures 3.8 through 3.10 show the relationship between the 5-
year impact factor (IF) and total retraction and correct notices, IF and total retraction notices, and 
IF and retraction notices for HRM only, respectively.  The Pearson correlative coefficient for each 
figure was 0.0119, 0.0182, and 0.0215, demonstrating limited correlative association between the 
two factors.    
 
Table 3.15  Journal 5-year Impact Factor and Total RNs 
Journal IF 
RN 
Totals 
Coronary Artery Disease 1.286 1 
Transplant Immunology 1.671 2 
Biomedical Chromatography 1.695 1 
International Journal of Radiation Oncology Biology Physics 2.009 1 
Acta Obstetricia et Gynecologica Scandinavica 2.057 1 
Cellular Immunology 2.14 1 
Endocrinology 2.142 2 
Urology 2.273 1 
Immunology Letters 2.345 1 
Current Opinion in Organ Transplantation 2.459 3 
Immunogenetics 2.466 1 
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Table 3.15 (Continued) 
Journal IF 
RN 
Totals 
Biochemical and Biophysical Research Communications 2.474 4 
Human Immunology 2.477 1 
Current Opinion in Molecular Therapeutics 2.72 1 
Hypertension Research  2.725 1 
European Journal of Clinical Investigation 2.915 1 
Genomics 2.917 1 
Brain Research 2.957 3 
Developmental Neuroscience 2.995 1 
Metabolism Clinical and Experimental  3.008 1 
Current Opinion in Investigational Drugs 3.01 1 
Journal of Neuroimmunology 3.062 1 
Diabetes and Metabolism 3.094 1 
Biochemistry 3.104 3 
Chemical Senses 3.142 1 
Immunology Research 3.172 1 
Journal of Trauma 3.204 6 
Oral Oncology 3.41 4 
Human Gene Therapy 3.435 1 
Journal of Neurophysiology 3.446 1 
Journal of General Virology 3.504 1 
Transplantation 3.582 8 
FEBS Letters 3.673 2 
Mutation Research/DNA Repair 3.679 2 
Journal of Molecular Biology 3.795 1 
Developmental Biology 3.812 1 
Genes, Chromosomes & Cancer 3.869 1 
Journal of Urology 3.902 2 
American Journal of Physiology: Cell Physiology 3.952 3 
Journal of Pharmacology and Experimental Therapeutics 3.959 1 
Fertility and Sterility 3.982 1 
Journal of Neurochemistry 4.022 1 
Infection and Immunity 4.096 2 
Journal of Applied Physiology 4.193 1 
Nature Cell Biology 4.295 3 
American Journal of Physiology -Lung cellular and molecular 
physiology  
4.338 1 
Molecular Pharmacology 4.596 1 
Journal of Leukocyte Biology 4.663 1 
Molecular Endocrinology 4.715 1 
Obstetrics and Gynecology 4.755 1 
Journal of Virology 4.855 5 
Journal of Biological Chemistry 4.863 19 
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Table 3.15 (Continued) 
Journal IF 
RN 
Totals 
American Journal of Physiology - Endocrinology and Metabolism  5.037 1 
Journal of Molecular and Cellular Cardiology 5.133 1 
American Journal of Pathology 5.205 1 
Glia 5.374 1 
Journal of Lipid Research 5.418 1 
International Journal of Cancer 5.497 1 
Journal of Immunology 5.57 15 
Molecular and Cellular Biology 5.614 7 
Carcinogenesis 5.815 1 
Journal of Infectious Diseases 6.02 1 
Sleep 6.229 2 
Journal of Bone and Mineral Research 6.52 1 
Journal of Pathology 7.224 1 
Hypertension 7.346 5 
Environmental Health Perspectives 7.607 1 
Journal of Neuroscience 7.648 1 
Oncogene 7.719 1 
Clinical Cancer Research 8.101 2 
Neurology 8.375 1 
Cancer Research 8.958 1 
Diabetes  9.105 1 
Blood 9.609 3 
EMBO Journal 10.168 4 
Journal of Cell Biology 10.437 1 
Plant Cell 10.656 1 
PNAS 10.727 14 
Circulation Research 10.759 2 
Journal of American Chemical Society 11.015 6 
Immunological Reviews 12.238 1 
Genes & Development 12.765 1 
Gastroenterology 12.951 1 
Developmental Cell 13.012 1 
Journal of Experimental Medicine 13.955 4 
Journal of Clinical Investigation 14.449 2 
Annals of Internal Medicine 16.482 1 
Neuron 16.485 1 
Immunity 20.948 6 
Nature Medicine 26.501 1 
Nature Genetics 32.138 2 
Science 34.463 7 
Cell 35.02 2 
Lancet 39.315 3 
 
 52 
 
Table 3.15 (Continued) 
Journal IF 
RN 
Totals 
Nature 40.783 3 
New England Journal of Medicine 52.426 3 
  
  
 Looking at the Journals for the ORI-referenced articles that did not have retractions or 
corrections affiliated with them (Table 3.16), only Molecular and Cellular Biology and the Lancet 
had other ORI-related retractions or corrections.  The Lancet had one RN HRM, one RN Error and 
one CN Error.  The Molecular and Cellular Biology had one RN HRM, four RN Error, one CN 
Error, and one CN NR.   
 
Figure 3.10  Impact Factors Compared to Total Retraction and Correction Notices 
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Figure 3.11  Impact Factors Compared to Total Retraction Notices 
 
 
Figure 3.12  Impact Factors Compared to HRM Retraction Notices 
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 A check of the Medline database showed that Comparative Biochemistry and Physiology 
Part C, Molecular and Cellular Endocrinology, Proceedings of the Royal Society of London, and 
Shock had errata (i.e., non-ORI misconduct findings) but no retractions listed. On the other hand, 
the Lancet, the Journal of Clinical Immunology and Annals of the New York Academy of Sciences 
had other (i.e., non-ORI misconduct findings) retraction notices in their archives.  With such a 
limited sample, no significance can be assigned to the lack of ORI-related retractions.   
 
Table 3.16 Journals referenced in ORI Findings with no RNs or CNs 
Journals from Table 4.11 
Impact 
Factor 
Number of ORI 
RN/CN located 
Shock  2.811 0 
Comparative Biochemistry and Physiology. C: 
Comparative Pharmacology. 
2.86 0 
Journal of Clinical Immunology.  3.276 0 
Annals of the New York Academy of Science   3.854 0 
Molecular and Cellular Endocrinology  4.219 0 
Molecular and Cellular Biology 5.614 7 
Proceedings of the Royal Society of London  5.808 0 
Lancet 39.315 3 
 
 No further assessment was performed on these articles in any subsequent counts of 
retractions or otherwise.  With such a small sample and no applicable comparison set, statistical 
analysis was not likely to be meaningful.      
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CHAPTER FOUR: 
DISCUSSION 
 
4.1 Evaluation of Research Hypothesis 
 The crux of this study is the hypothesis that the number of retractions attributed to 
misconduct do not adequately convey the incidence of misconduct occurring in hard science 
research.  Retraction studies repeatedly suggest that the rate of retractions is an adequate measure 
of the incidence of research misconduct, and that the low proportion of retractions to total articles 
indicate a minimal incidence of research misconduct.  In this study of Subjects sanctioned for 
research misconduct, less than half (49.7%) of the Subjects had authorship on a published article 
stemming from the research in question and only 22.2% of the Subjects had an article with a 
retraction attributed to their research misconduct.  
 If retractions were a reasonable measure of research misconduct, one would expect that a 
majority of these Subjects, having a documented finding of research misconduct, would have a 
retraction attributed to misconduct.  Instead, only small minority of Subjects had such retractions, 
while two Subjects had no retractions or even corrections at all, despite having authorship of ORI-
referenced articles. Thirteen articles referenced as products of research misconduct had no 
associated retraction or correction notice, even though the ORI finding specifically addressed the 
six articles as requiring retraction or correction, or as already having such requests already 
submitted. 
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 Including all retractions and corrections without regard to the verbiage assigning cause to 
the notice, the average notice per ORI-sanctioned Subject was 1.38 notices per Subject.  The 
argument may therefore be that the overall numbers of retractions as located in general publication 
searches might be indicative of the overall number of researchers committing misconduct.  This 
flawed reasoning is equivalent to the suggestion that of the $340,850,358 in property value stolen 
in robberies in the United States during 2012 (Meixell and Eisenbrey, 2014), each of the estimated 
238,000,000 million adults living in the United States at that time (US Census Bureau. 2012) 
would have been responsible for a robbery of roughly $1.30. (My conscience and criminal record 
is quite clear.) Thus, the hypothesis that the use of retraction numbers is an inadequate measure of 
research misconduct incidence appears to hold true. 
  
4.2 Evaluation of General Demographics  
 Retraction studies have also attempted to characterize researchers who commit misconduct 
by the information available within each retraction or correction.  However, this study failed to 
show statistical strength in correlations between the number of retraction notices, with or without 
the inclusion of correction notices and educational level or positional responsibilities.   
 
 4.2.1 Education Level 
 A strong correlation between a Ph.D. and the number of misconduct-related retractions and 
corrections was expected, simply because the Ph.D. is generally considered as a research-related 
degree encompassing numerous publications, while MD or DVM might be more likely to engage 
in non-research practices only.  While Ph.D.’s were disproportionately higher in the findings 
 57 
 
(again, as would be expected by the very nature of the degree), the number of retractions and 
corrections showed no strong correlation to Ph.D. Subjects (Table 4.4).   
 Little, if any, meaning can be attached to this information.  Educational status does not 
always correlate with job function or responsibilities, and no information was available to discern 
exactly what the relationship of the degree itself was to the misconduct incident. Unless one 
forwards the argument that graduate curriculum actually increases the likelihood of a student to 
commit fraudulent behavior or entices criminal aficionados, characterizing researchers based on 
degree alone is likely to be as misleading as counting the number of retractions themselves.   
  
 4.2.2 Professional Positions 
 The majority of ORI misconduct findings identified the position held by Subject at the time 
of the misconduct.  In the findings that failed to provide some type of position title other than 
“employee”, outside sources were searched for the professional title held by the Subject at that 
time.  The span of responsibility identified in the misconduct findings extended from staff assistant 
to department director.  More than two-thirds of the positions appeared to be associated with 
academic institutions, although some Subjects were associated with private industry or 
governmental regulatory agencies.  Because ORI investigations are predicated on the involvement 
of NIH/PHS grants, assuming an association between the prevalence of misconduct and academic 
institutions is fundamentally flawed.  Federal funding provides almost 70% of all academic 
research funding, of which the NIH is the largest funding source (NSB, 2012).  Since private 
industry generally accounts for greatest proportion of funding for biomedical research (Dorsey et 
al., 2010), it is unlikely that they also would be proportionally represented in receipt of NIH 
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funding and consequentially  proportionally subjected to ORI reviews of misconduct allegations 
and subsequent misconduct findings.  
 To complicate matters, and assuming the positon title within each ORI finding was 
accurate, the professional position title(s) held by each Subject at the time of the misconduct event 
must be considered distinct since each institution defines professional duties according to their 
own policies and procedures, making categorization by position title alone difficult.  A “research 
assistant” at one institution might have considerably different responsibilities at a different 
institution, or the position duties may have changed substantially over a period of years.  With this 
in mind, no attempt was made to assess the proportion of professional positions alone in the 
misconduct counts.  However, a few important details stand out.  
 The position category of Technician included 16 Subjects (9.6%).  These Subjects held 
positions unlikely to be directly involved in the production of a manuscript for publication or 
named as coauthor.  Furthermore, they are also unlikely to be detected unless observed and 
reported by another, or when analysis results appear noticeably aberrant.  A retraction is unlikely 
to present a “red flag” for other articles concerning such research in which the Subject was working 
unless an intensive investigation identifies a source.  A researcher who suspects fraudulent work 
by institution technicians post-publication may retract an article; this retraction will not be 
representative of the number of persons who actually committed the misconduct unless the 
retraction provides such information.   Information as to the total number of involved persons may 
not even be available at the time the retraction request is made.  Marshall (2000) interviewed a 
scientist whose own research had been affected by misconduct.  After one of the scientist’s 
epidemiologists found anomalies in the data set, the scientist was able to identify an employee who 
fabricated interviews and other data in the early phases of the study. The researcher then worked 
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to validate all interview data gathered up to that point; “an epidemic of falsification” by employees 
permeated throughout the entire study’s interview dataset.  Diligence and an intense process of 
checks and rechecks was the only safeguard against publication of a fraud-laden research article.  
No retraction existed to serve as marker of this fraudulent behavior. 
 The importance of considering professional positon titles lies then in noting that 
misconduct findings have been made against broad spectrum of persons involved in all facets of 
research,  lending credence to the concept that article retractions cannot indicate the breadth and 
depth of research misconduct.  In short, anyone who works in a research-related role can and may 
commit research misconduct, regardless of potential authorship or manuscript contributory roles. 
 Reviewing the ORI misconduct findings uncovered a somewhat more disturbing 
implication.  Although many of the position titles were prefaced by the term “former”, this in no 
way indicated that the Subject no longer worked at the same institution, no longer worked in a 
research capacity or that professional advancement can be halted by a misconduct finding.  Several 
Subjects have remained at the same institution in which they were employed at the time of the 
finding, and still others have changed institutions while still remaining in a research role. The 
assumption that institutional sanctions (ORI or otherwise), with or without retractions, may serve 
as sufficient determent for future misconduct does not seem to hold much strength.  John C 
Hiserodt, debarred by ORI from participating in federally-funded research in 1994 for extensive 
falsification and fabrication, continued to participate, despite repeated admonishments from 
university officials, in such research at the University of California at Irvine until a 1997 
investigation intervened (Blumenstyk, 1999). Paul Kornak received a lifetime debarment in 2006 
after multiple episodes of fraud and misconduct up to 2002, some of which resulted in the death 
of at least one study subject, most of which occurred after a sanction was imposed in 1993. (Kornak 
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was convicted of criminal negligent homicide, as well as other criminal charges for his behavior.)  
Fortunately, repeated incidents as these appear to be rare, but may none-the-less indicate that 
fraudulent behavior may be more ingrained in the researcher than in the research environment.  
 
4.3 Evaluation of Authorship and Journals Findings  
 The role of journal publishers and editors in the retraction of papers cannot by understated. 
Retraction notices are published at the discretion of the publishers and editors, who may or may 
not act in concurrence with the authors and/or investigating institution.  Only 46 journals (46%) 
of the journals in this study published at least one retraction giving misconduct as cause.  Of the 
46 journals, three (EMBO Journal, PNAS, and the Journal of Immunology) also published 
correction notices with references to misconduct.  Among the journals without any misconduct 
retractions, nine journals published correction notices with misconduct as cause.  Hence, only 54% 
of the ORI-referenced journals, all editors of whom presumably having knowledge of an article 
within their publication containing fraudulent information since ORI investigations involving 
contact with the journals, chose to issue a misconduct-related retraction or correction.  Only 40.6% 
of the ORI-referenced articles had misconduct-related retractions or corrections published, 
although it was the largest of the four categories of notices. Error (38.1%) was the second largest 
stated cause for a retraction or correction (keeping in mind that misconduct confirmed by an 
institutional investigation was the actual originating cause). Curiously, more corrections were 
issued for error than for misconduct, while more retractions were issued for misconduct than error. 
Without conversations with the journal editors, journal publishers, and article authors speculations 
as to this conundrum carries little weight.   What remains clear, however, is that explanations as 
to cause for retraction or correction notice are about as likely to be as false as they are factual.   
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 Understanding the cause for a retraction or correction has great significance to the general 
body of knowledge, and journal editors and publishers hold great influence as to how that body 
fares.  However, not all editors seem cognizant of the issues of fraudulent research resulting in 
fraudulent articles.  A survey of Wiley-Blackwell editors indicted that the majority did not consider 
issues of research ethics a major or frequent problem in their publications (Wager et al., 2009).  
The study authors acknowledged study weaknesses in that less than half the surveys were returned, 
but no indication was given in the study as to the journals retraction and correction rate and yearly 
article publishing numbers for each journal, which may have been a factor in their exposure to 
such problems.  On the other hand, it is difficult to consider their lack of awareness of these issues, 
as more recent studies have indicated the problem as “disturbingly frequent” (Wager et al.,  2009).  
 In describing case histories of rejected manuscripts, Gut editor Michael Farthing (1997) 
described what happened when he sent a rejection notice of a manuscript to both listed authors due 
to “fundamental flaws in the methods”. The coauthor faxed him a response stating “he [the 
coauthor] had not seen the article, had not been involved in its preparation, and had not given 
consent to be a co-author”  Farthing received an apology from the submitting author, “indicating 
an absence of knowledge regarding the conventions of not submitting a paper simultaneously to 
more than one journal and the requirements of authorship.”  Farthing did not provide an 
explanation for the disparity between the apology based on simultaneous submissions and the lack 
of coauthor knowledge of and involvement in manuscript preparation, nor did he indicate he sought 
one.  Based on the immediacy of a fax and its content by the co-author, publishing protocols might 
not have been the central issue with the submitting author.     
 Editors and publishers may also lack the power to protect the knowledge body effectively.  
The absence of an official misconduct finding on the part of a government agency or academic 
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institution may cause hesitancy for publishers or editors to issue a misconduct-based retraction or 
correction for liability reasons (Resnik and Dinse, 2013).  If misconduct is merely suspected, a 
journal may or may not have the financial wherewithal to hire sufficiently-skilled reviewers for 
data or image analysis.  The case of the British Medical Journal (BMJ) and Dr. Ram B. Singh is a 
case in point. 
 As told by Carolyn White, BMJ’s Press officer, BMJ spent over 10 years attempting to 
confirm research misconduct against one of its contributing authors (a Dr. Singh), but was unable 
to do so for lack of funds, time, and regulatory institutional support (White, 2005).  According to 
White, BMJ attempted to build a collaboration with the American Journal of Cardiology (AJC) to 
investigate Dr. Singh’s works, but AJC declined due to financial reasons.   
 Furthermore, unless any or all authors agree to comply with the sanctions in a misconduct 
finding, a journal can find themselves embroiled in a lengthy and therefore costly legal battle.   
Molecular Pharmacology stepped away from a notice of concern over fear of litigation. (Couzin 
and Unger, 2006). In the case of Joachim Boldt, whose fraudulent practices prompted a formal 
request from the State Medical Association of Rheinland-Pfalz (Germany) for the retraction of 88 
articles from 18 journals, only 79 articles were actually retracted. Three journal publishers 
reportedly would not retract 6 of the articles due to legal threats from Boldt’s attorneys (Elia et al., 
2014).   Clearly, without the assent of the author or extensive fiscal resources to obtain expert 
analysis and to withstand legal challenges, retraction or even correction of articles containing 
fabricated or falsified data is neither a simple nor guaranteed process.   
 Many retraction studies have theorized that researchers who commit misconduct are more 
likely to target higher impact journals than lower impact journals.  Despite this much-advocated 
relationship, the Pearson correlation coefficient showed little association between the 5-year 
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impact factor and total retraction notices, total retractions and corrections, and total hard research 
misconduct-related retractions in the ORI misconduct findings.  Proportionally the higher-impact 
factor journals were underrepresented in the IF data (23 journals with IF>10, 73 journals < 10), 
but it is unlikely that this would have masked the association to any large extent.    
 One significant weakness in the theory of higher impact factor journals being targeted by 
researchers who commit misconduct is in the retraction studies’ datasets themselves, which is 
generally limited to the counts of retracted and/or corrected articles alone. A tracking of the total 
number of published articles (retracted, corrected and intact) per researcher per journal would be 
necessary to show any true relationship.  If nothing else, the alleged higher number of misconduct 
retractions in higher impact journals speaks more to journal publishing policy than to author intent; 
the journals with higher impact factors may simply be more diligent in removing questionable 
articles than merely correcting them (Wager and Williams, 2011). 
 
4.4  Public Health Implications 
 Preventing research misconduct is not merely an attempt to preserve the sanctity of the 
written word.  Fraudulent research poses a distinct threat to the public’s health and well-being, and 
the more often it reaches publication, the larger the threat it poses.  The well-publicized surge in 
measles outbreaks in the United States stems in large part from Andrew Wakefield’s fraudulent 
and subsequently retracted study linking autism to the MMR vaccination (Wakefield et al., 1998).  
Declared eradicated in the United States by 2000, measles outbreaks are increasing in frequency 
and have now been recorded in 27 states and the District of Columbia (CDC, 2015), because of 
the lack of vaccination by Wakefield’s adoring, if not deluded, followers . The ORI-sanctioned 
researcher Paul Kornak was convicted of criminally negligent homicide for the death of one of his 
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study subjects; others were suspected but not proven.  Novel oncology protocols, subsequently 
found to be invalid, were used to treat cancer patients based on now-retracted publications by 
former Duke researcher Anil Potti (Jha, 2012).  Because of fraudulent publications on beta-
blockers by Dr. Eric Poehlman, an estimated 162 out of 5254 trial participants may have died due 
to invalid trial treatment protocols based primarily on his research (Chopra et al, 2012).  The 
concept of science as a self-correcting institution may yet remain true, but begs the question of at 
what cost to human life.   
 As this study showed, even using retractions themselves to discern which studies may be 
fraudulent limits the detection of actual fraud-embedded articles. There is a decided lack of 
standardization in journal retraction notices (Davis, 2012), and authors and editors alike may 
assign any number of reasons to a retraction or correction, regardless of originating cause.  A 
proportion of the retraction or correction notices for articles in this study containing falsified or 
fabricated data or images used  the excuse “failure to reproduce the study’s findings” or some 
equivalent phrasing.  Irreproducibility is a significant problem throughout biomedical sciences 
with some studies suggesting reproducibility rates as low as 25% (Prinz et al, 2011).  Freedman et 
al (2015), basing their findings on a meta-analysis of 5 reproducibility studies, gave an estimated 
53% irreproducibility rate with a cumulative direct cost of $28.2 billion in wasted research, and 
up to $1 million wasted in futile attempts to replicate the findings. Researchers at Amgen attempted 
to reproduce the findings of 53 clinical trials in oncology, and succeeded in only 6 of the trials – 
an 88.7% irreproducibility rate (Begley and Ellis, 2012).  Authors Begley and Ellis point out the 
downstream risks – that further trials were conducted based on the non-reproducible studies 
“suggesting that many [cancer] patients had subjected themselves to a trial of a regimen or agent 
that probably won’t work.”  Theories for the low reproducibility rates usually assigned poor 
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statistical power or analyses, or even errors made in the rush to publish; misconduct is rarely 
offered as a cause.  Prinz et al (2011) found no correlation for reproducibility versus journal impact 
factor or number of articles, two factors retraction studies usually associated with misconduct.  
Likewise, this study of retractions directly resulting from fraudulent research showed no 
correlation for the same two factors, suggesting then that a study’s “irreproducibility” commonly 
masks an underlying case of research misconduct.  
 
4.5 Economics of Research Misconduct 
 Financial costs to research misconduct are almost as grave as the human cost.  Michalek et 
al (2010) approached the analysis as a three part cost issue:  the fraudulent research, the 
investigation and remediation.  Total costs estimated for an actual case study of fabricating data 
and images in a federal grant application were over $538,000 in direct costs, roughly $40,000 in 
equipment and facilities maintenance, and roughly $1,200,000 in lost grants.  Other costs were 
mentioned without specific quantification (such as costs of maintaining all records for the requisite 
6 years from finding), but at a minimum a research misconduct case can accumulate direct and 
indirect costs exceeding $1,700,000 (Figure 4.1).   
 Research misconduct costs estimated by Stern et al (2014) are far more conservative. Costs 
to funding sources for each retracted article averaged $239,381.06 for all retracted journals and 
$361,905.44 for NIH-funded retracted articles, based on averaging of total NIH grant 
disbursements.  However, the study authors acknowledged that the calculations do not include the 
downstream costs of the research misconduct, such as iatrogenic injury from treatment protocols 
developed from the fraudulent research.  Omitted as well are the research costs when attempts to 
replicate these fraudulent findings fail as well as the costs of the investigation.    
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Figure 4.1 General  Estimates of Costs of Research Misconduct 
(adapted from Michelek et al., 2010) 
 
 Gammon and Franzini (2013) divided research misconduct costs into four categories: 
investigative, grant award loss, voluntary exclusion agreement (ORI’s settlement document) and 
retraction costs.  Using 17 ORI misconduct investigation cases settled from 2000 to 2005, they 
calculated total costs ranging from $116,000 to $2,192,620, with  median of $170,223.   
 Lacking in most if not all the economic studies are quantification of the litigation costs.  
University of Utah and University of California at San Diego were required to pay the Federal 
Government $1.6 million under the False Claims Act (Hilts, 1994).  Duke University only recently 
settled lawsuits for undisclosed amounts to cancer trial patients, patient families and patient estates 
for the fraudulent research conducted by Anil Potti (Upchurch, 2015).   
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4.6 New Ways to Examine Research Misconduct  
 The weakness in using retractions as a means to gauge incidence or prevalence of research 
misconduct or even discern likely characteristics of researchers committing misconduct lies within 
the process of publication production itself.  Consider the overall chain of events necessary into 
publish a retraction for an article produced from fraudulent research (Figure 4.2).  Numerous steps 
allowing multiple interferences prevent the end variable (retractions for misconduct) to be a viable 
measure of the original variable (misconduct).  Clinical trials, the proverbial “gold standard” of 
research where associations merge closer to causation, eliminate confounds and extraneous 
variables that may influence the dependent variable.  No longer is it acceptable to judge the 
hypertension treatment successful by blood pressure measurement years or even months after a 
trial subject records eating oatmeal for breakfast. Yet, in essence, retraction studies are 
retrospective studies that do just that.   
 Reliable methods of determining research misconduct prior to manuscript publication are 
here-to-fore speculative.  One researcher whose study was a victim of research misconduct said 
that the lesson he learned was to “validate the work yourself” (Marshall, 2000).  For small studies, 
cross-validation by the principal investigator may be possible, but for large studies involving 
multi-centered research projects encompassing thousands of trial participants such safety measures 
are impractical and probably impossible.  Furthermore, this throws the burden of research 
misconduct on the victim and not on the perpetrator, much like blaming a credit-card holder for 
fraudulent purchases made by a computer hacker.    
 Reliance on coworkers or subordinates to report misconduct potentially opens doors to 
malicious reports arising from illegitimate intentions.  In defense of such reports, Price (1998a)  
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Figure 4.2  Flow Chart From Misconduct to Retraction 
 
noted that only 8% of allegations received by the ORI from 1993 through 1997 were anonymous, 
suggesting that the majority of reports are traceable and thus less likely with abusive intent. Paola 
et al. (1998), from a survey of 119 deans of medicals schools, found that 56% of the deans reported 
having received anonymous letters casting aspersions on one or more faculty members, with over 
 69 
 
half the deans initiating an investigation based on the letter, while the others either discarding it or 
merely filing it for recordkeeping.  Paola et al. did not report whether the investigations validated 
the accusations in the letters or not, as the basis for the report was the concern over the acceptance 
of anonymous complaints.  In a subsequent reply to a similar question by Price, Paola et al. (1998b) 
clarified that they did indeed find it preferable for recipients of anonymous allegations to 
“categorically discard” any report.  However, it does seem possible that, contrary to Paola et al.’s 
intent, acceptance of anonymous letters as an impetus for investigations may serve an actual 
beneficial purpose more so than a detestable one.   
 Statistical measures to review data for fraud detection have also been suggested.  Al-
Marzouki, Evens et al. (2005) analyzed the data from two clinical trials using techniques such as 
“digit preference”, i.e., the tendency of people to prefer certain numbers.  Their analysis cast doubt 
on the randomization of the participants of one trial, which was already under suspicion for data 
manipulation.  The underlying concept was that fabrication and falsification of data have inherent 
traits different to the randomness of natural error and typical to each person.  With the advent of 
computer randomization programs however, this method may only detect those who use limited 
technological resources for falsification or fabrication.  It does bear mention that the fraud of the 
Duke researcher Anil Potti was discovered by the statistical analyses performed by MD Anderson 
biostatisticians (The Economist, 2011). 
 In attempting to resolve the problems of research misconduct, the focus on retraction 
appears misdirected.  Curbing retractions will not directly curb research misconduct and risks 
merely causing greater creativity in the creation of fraudulent research notebooks, instrument 
readouts, chemical assay solutions, peer-review systems, etc.  Peer-review processes may actually 
be providing an avenue for fraudulent research articles.  In one case, an author suspected of 
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misconduct repeatedly submitted manuscripts to journals – even the ones who were questioning 
his prior manuscripts (White, 2005).  Quoting one of the investigators, White wrote, “Every time 
the errors on [his] manuscripts were pointed out, they were cleaned up for the next submission.  
So in effect the reviews were giving him a tutorial.”   Furthermore, over the last three years at least 
110 retractions occurred from six separate fraudulent peer-review systems, where false identities 
and emails were created to allow fraudulent manuscripts to reach publication (Fountain, 2014; 
Ferguson, et al., 2014).  A current publishing plague is referred to as “spoof” papers, where 
nonsense manuscripts are sent to journals as a test of the journals reviewing prowess.  Over 120 
papers were retracted from one journals after they were shown to be computer-generated, and not 
actual manuscripts based on actual research (Foley, 2014).  The computer program to create the 
nonsense papers was developed by graduate students and is still freely available for use online at 
http://pdos.csail.mit.edu/scigen/.  
 Productive steps towards curbing research misconduct require adopting a new approach.  
Utilizing investigatory and profiling techniques from criminology may prove more successful than 
the past retraction studies (Furman et al., 2012; Hesselmann et al., 2014).  A few studies have taken 
to looking more closely at the individuals who commit research misconduct in order to determine 
contributory factors.  Redman et al (2006) examined the records of clinical staff subjected to ORI 
misconduct investigations and found managerial issues of work overload, lack of delegation and 
lack of authority to be common work environments in which these clinical staff work.  Marshall 
(2000) interviewed a researcher whose own research had been affected by research misconduct.  
The researcher in question speculated that time pressures may have caused interviewers to 
fabricate data to meet deadline requirements. In a Nature article, Virpul Bhrigu offered an 
explanation for his sabotage of another researcher’s work by saying, “I just got jealous of others 
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moving ahead and I wanted to slow them down” (Maher, 2010).  Dong-Pyou Han, one of the few 
researchers ever criminally convicted regarding research misconduct events, assigned the 
beginnings of his massive fraudulent behavior to attempts to cover an error he made in samples 
years ago (Reardon, 2015).  Suggestions of external pressures by industry and government 
agencies trying to drive policies in particular directions is also a speculative motive (Tong and 
Olsen, 2005), but there has been no credible research that conveys the extent to which this actually 
occurs, although realistically it cannot be discounted.  Puigdomènech (2014) suggests that as 
money and promotion opportunities increased, so would incidents of research misconduct.   
 Other studies have suggested a motivation for research misconduct is the desire for 
publication in high impact journals or for the production of “a note-worthy paper” (Steen, 2014).  
However, while I performed no personal interviews with any of the Subjects for whom there is an 
ORI misconduct finding, it seems unlikely that the production of a published article would be the 
driving motivation for staff assistants or phlebotomists, whose names would be unlikely to appear 
on the article.  This is not to say that the “publish or perish” axiom has no bearing on research 
misconduct; the spectrum of job roles imply a similar spectrum of motivations for involvement in 
research misconduct.  A small percentage of economists in the European Economic Association 
admitted to sexual liaisons in exchange for research misconduct, publishing credit or promotional 
advantage (Necker, 2014).  This data set is indeed limited and has more innate bias than broader 
studies on retractions over multiple journal categories.  However, motivations for committing 
research misconduct would more likely be detected by looking at the person committing the 
misconduct rather than by studying retractions as an end result.   
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4.7 Study Limitations 
 All research studies have limitations, and this one is no different.  The first and possibly 
most notable is the lack of cross-checks and data quality cross-checks as only one person 
performed all database searches, data input, and statistical analyses.  Additional obvious 
limitations are the lack of print journal searches for retraction and corrections, a lack of 
determination of total publishing rates for each Subject, and assumptions of consistency of 
behavior between NIH-funded researchers and non-NIH-funded researchers. 
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CHAPTER FIVE: 
SUMMARY 
 
 This study of retractions and corrections associated with ORI misconduct findings showed 
three important traits:   
 1.  Misconduct in research is not always associated with the production of an article.   
 2.  If an article is known to contain fraudulent data, it still may not be retracted.  It may 
merely be corrected, or may not be amended at all.   
 3. Retraction and correction notices are more likely to contain  incorrect information as to 
cause than to contain information assigning cause to misconduct.   
If retractions are indeed a sound measure of the incidence of research misconduct, then research 
misconduct may proportionally be a limited occurrence.  However, if research misconduct is, as 
suggested by this study, found to be more far-reaching than retractions convey, there is little 
likelihood that concentration on the statistical analysis of retractions is adequate for discerning the 
true incidence and prevalence of misconduct. 
 However, spending more resources attempting to quantify the rate of research misconduct 
seems unnecessary and wasteful.    Very few problems as pervasive as unethical behavior (such as 
manifested by research misconduct) can begin to be resolved without a thorough understanding of 
the depth and breadth of the issues.  Effective problem-solving requires one address the causative 
factors and focusing on retractions only misdirects the attention to the end result of misconduct. 
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 Simply put, it comes down to choices.  If the interest is in protecting the reputation and 
sanctity of biomedical and health-related journals, then by all means – pursue the interest in 
retractions, and throw in corrections as well.  Improve pre-publication peer-reviews, insist on 
submission of data with the manuscript, have every author sign a form stating that the manuscript 
can be withdrawn, retracted or amended at the whim of the publisher or editor, and standardize 
language and notices of retraction and correction.  Submissions will receive better scrutiny, better 
substantiation, less fuss from authors about retractions/corrections and easier discovery on 
searches for such information.   
 On the other hand, if reducing the incidence and prevalence of research misconduct, 
protecting public health, lowering risks of morbidity and mortality from fraudulent research, and 
conserving financial, equipment and manpower resources wasted on fraudulent research 
misconduct, then the time is now to move away from studies of retractions.  Effort and resources 
should be invested instead in better oversight, division of labor and accountability, and discovery 
and investigation as to actual causes and indicators of research misconduct. 
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